Cluster composition

Functions

Category	Name	IntersectionWithQuery	PValue	GenesInTerm	GenesInQuery	GenesInTermInQuery	ID
GeneOntologyMolecularFunction	transferase activity, transferring phosphorus-containing groups	FLT1 FLT3 FLT4 SPEG PAK5 LRRK2 STK38 DGKH PFKFB4 REV3L CHKA PARP14 MELK CDK10 MB21D2 CHPT1 PIK3CA CDK13 PRKCD FGFR1 FGFR2 CDK11B POMK	2.33e-08	938	127	23	GO:0016772
GeneOntologyMolecularFunction	phosphotransferase activity, alcohol group as acceptor	FLT1 FLT3 FLT4 SPEG PAK5 LRRK2 STK38 DGKH PFKFB4 CHKA MELK CDK10 PIK3CA CDK13 PRKCD FGFR1 FGFR2 CDK11B POMK	1.16e-07	709	127	19	GO:0016773
GeneOntologyMolecularFunction	protein kinase activity	FLT1 FLT3 FLT4 SPEG PAK5 LRRK2 STK38 CHKA MELK CDK10 PIK3CA CDK13 PRKCD FGFR1 FGFR2 CDK11B POMK	2.63e-07	600	127	17	GO:0004672
GeneOntologyMolecularFunction	kinase activity	FLT1 FLT3 FLT4 SPEG PAK5 LRRK2 STK38 DGKH PFKFB4 CHKA MELK CDK10 PIK3CA CDK13 PRKCD FGFR1 FGFR2 CDK11B POMK	3.64e-07	764	127	19	GO:0016301
GeneOntologyMolecularFunction	benzodiazepine receptor binding	RIMBP3 RIMBP3C RIMBP3B	2.49e-06	5	127	3	GO:0030156
GeneOntologyMolecularFunction	protein tyrosine kinase activity	FLT1 FLT3 FLT4 CHKA MELK PRKCD FGFR1 FGFR2	4.12e-06	145	127	8	GO:0004713
GeneOntologyMolecularFunction	minus-end-directed microtubule motor activity	DNAH7 DNAH17 DNAH6 DNAH11	4.46e-06	18	127	4	GO:0008569
GeneOntologyMolecularFunction	vascular endothelial growth factor receptor activity	FLT1 FLT3 FLT4	8.63e-06	7	127	3	GO:0005021
GeneOntologyMolecularFunction	dynein light intermediate chain binding	DNAH7 DNAH17 DNAH6 DNAH11	2.84e-05	28	127	4	GO:0051959
GeneOntologyMolecularFunction	ATP-dependent activity	ABCB7 HSP90AB4P ABCC11 IDE DNAH7 SLFN13 EIF4A2 DNAH17 TMEM30A HFM1 DHX32 ATP6V1C2 DNAH6 DNAH11	3.70e-05	614	127	14	GO:0140657
GeneOntologyMolecularFunction	transmembrane receptor protein tyrosine kinase activity	FLT1 FLT3 FLT4 FGFR1 FGFR2	5.85e-05	65	127	5	GO:0004714
GeneOntologyMolecularFunction	dynein intermediate chain binding	DNAH7 DNAH17 DNAH6 DNAH11	8.76e-05	37	127	4	GO:0045505
GeneOntologyMolecularFunction	protein serine kinase activity	SPEG PAK5 LRRK2 STK38 MELK CDK10 PIK3CA CDK13 PRKCD CDK11B	1.11e-04	363	127	10	GO:0106310
GeneOntologyMolecularFunction	ATP hydrolysis activity	ABCB7 HSP90AB4P ABCC11 IDE DNAH7 SLFN13 EIF4A2 HFM1 DHX32 DNAH6 DNAH11	1.20e-04	441	127	11	GO:0016887
GeneOntologyMolecularFunction	transmembrane receptor protein kinase activity	FLT1 FLT3 FLT4 FGFR1 FGFR2	2.10e-04	85	127	5	GO:0019199
GeneOntologyMolecularFunction	fibroblast growth factor receptor activity	FGFR1 FGFR2	3.96e-04	5	127	2	GO:0005007
GeneOntologyMolecularFunction	growth factor binding	FLT1 FLT3 FLT4 IL1RAPL1 FGFR1 FGFR2	4.91e-04	156	127	6	GO:0019838
GeneOntologyMolecularFunction	protein serine/threonine kinase activity	SPEG PAK5 LRRK2 STK38 MELK CDK10 PIK3CA CDK13 PRKCD CDK11B	5.71e-04	446	127	10	GO:0004674
GeneOntologyMolecularFunction	cyclin-dependent protein serine/threonine kinase activity	CDK10 CDK13 CDK11B	9.00e-04	30	127	3	GO:0004693
GeneOntologyMolecularFunction	cyclin-dependent protein kinase activity	CDK10 CDK13 CDK11B	9.00e-04	30	127	3	GO:0097472
GeneOntologyMolecularFunction	microtubule motor activity	DNAH7 DNAH17 DNAH6 DNAH11	1.03e-03	70	127	4	GO:0003777
GeneOntologyMolecularFunction	inorganic molecular entity transmembrane transporter activity	CACNA1A CACNA1E TRPM4 SLC26A5 ABCC11 ANO5 PKDREJ TMEM38B GLRB SLC38A7 ATP6V1C2 SLC23A1 GABRA4	1.09e-03	758	127	13	GO:0015318
GeneOntologyMolecularFunction	voltage-gated calcium channel activity involved in regulation of cytosolic calcium levels	CACNA1A CACNA1E	1.40e-03	9	127	2	GO:0099511
GeneOntologyMolecularFunction	voltage-gated calcium channel activity involved in regulation of presynaptic cytosolic calcium levels	CACNA1A CACNA1E	1.40e-03	9	127	2	GO:0099626
GeneOntologyMolecularFunction	monoatomic ion transmembrane transporter activity	CACNA1A CACNA1E TRPM4 SLC26A5 ANO5 PKDREJ TMEM38B CHRNB2 GLRB SLC38A7 ATP6V1C2 SLC23A1 GABRA4	1.63e-03	793	127	13	GO:0015075
GeneOntologyBiologicalProcess	actin filament fragmentation	DSTN CFL1 CFL2	9.08e-07	4	127	3	GO:0030043
GeneOntologyBiologicalProcess	neuromuscular synaptic transmission	CACNA1A CHRNB2 RIMBP3 RIMBP3C RIMBP3B	2.65e-06	36	127	5	GO:0007274
GeneOntologyBiologicalProcess	phospholipid metabolic process	ACP6 SPTLC2 AGPAT4 DGKH CHKA TMEM38B SMPDL3B CHPT1 PIK3CA PLA2G4A PRKCD PLCB2	8.90e-06	410	127	12	GO:0006644
GeneOntologyBiologicalProcess	fibroblast growth factor receptor signaling pathway involved in orbitofrontal cortex development	FGFR1 FGFR2	3.76e-05	2	127	2	GO:0035607
GeneOntologyBiologicalProcess	phospholipid biosynthetic process	ACP6 SPTLC2 AGPAT4 DGKH CHKA TMEM38B CHPT1 PIK3CA PLA2G4A	4.30e-05	268	127	9	GO:0008654
GeneOntologyBiologicalProcess	positive regulation of actin filament depolymerization	DSTN CFL1 CFL2	7.90e-05	14	127	3	GO:0030836
GeneOntologyBiologicalProcess	ventricular zone neuroblast division	FGFR1 FGFR2	1.12e-04	3	127	2	GO:0021847
GeneOntologyBiologicalProcess	orbitofrontal cortex development	FGFR1 FGFR2	1.12e-04	3	127	2	GO:0021769
Domain	Kinase-like_dom	FLT1 FLT3 FLT4 SPEG PAK5 LRRK2 STK38 CHKA MELK CDK10 PIK3CA CDK13 PRKCD FGFR1 FGFR2 CDK11B POMK	2.01e-07	542	129	17	IPR011009
Domain	ADF/Cofilin	DSTN CFL1 CFL2	3.22e-07	3	129	3	IPR017904
Domain	Prot_kinase_dom	FLT1 FLT3 FLT4 SPEG PAK5 LRRK2 STK38 MELK CDK10 CDK13 PRKCD FGFR1 FGFR2 CDK11B POMK	1.46e-06	489	129	15	IPR000719
Domain	PROTEIN_KINASE_DOM	FLT1 FLT3 FLT4 SPEG PAK5 LRRK2 STK38 MELK CDK10 CDK13 PRKCD FGFR1 FGFR2 CDK11B POMK	1.61e-06	493	129	15	PS50011
Domain	Protein_kinase_ATP_BS	FLT1 FLT3 FLT4 SPEG PAK5 LRRK2 STK38 MELK CDK10 CDK13 PRKCD FGFR1 FGFR2	2.27e-06	379	129	13	IPR017441
Domain	-	FLT1 FLT3 FLT4 SPEG MCAM IFNLR1 RIMBP3 IL1RAPL1 HHLA2 CD19 RIMBP3C FGFR1 IL1RL1 FGFR2 IGSF1 RIMBP3B IL23R	3.21e-06	663	129	17	2.60.40.10
Domain	PROTEIN_KINASE_ATP	FLT1 FLT3 FLT4 SPEG PAK5 LRRK2 STK38 MELK CDK10 CDK13 PRKCD FGFR1 FGFR2 CDK11B	3.57e-06	459	129	14	PS00107
Domain	Ig-like_fold	FLT1 FLT3 FLT4 SPEG MCAM IFNLR1 RIMBP3 IL1RAPL1 HHLA2 CD19 RIMBP3C FGFR1 IL1RL1 FGFR2 IGSF1 RIMBP3B IL23R	7.37e-06	706	129	17	IPR013783
Domain	Tyr_kinase_rcpt_3_CS	FLT1 FLT3 FLT4	1.76e-05	8	129	3	IPR001824
Domain	RECEPTOR_TYR_KIN_III	FLT1 FLT3 FLT4	1.76e-05	8	129	3	PS00240
Domain	IG	FLT1 FLT3 FLT4 SPEG MCAM IL1RAPL1 HHLA2 CD19 FGFR1 IL1RL1 FGFR2 IGSF1	3.57e-05	421	129	12	SM00409
Domain	Ig_sub	FLT1 FLT3 FLT4 SPEG MCAM IL1RAPL1 HHLA2 CD19 FGFR1 IL1RL1 FGFR2 IGSF1	3.57e-05	421	129	12	IPR003599
Domain	ADF	DSTN CFL1 CFL2	3.73e-05	10	129	3	SM00102
Domain	Cofilin_ADF	DSTN CFL1 CFL2	3.73e-05	10	129	3	PF00241
Domain	ADF_H	DSTN CFL1 CFL2	3.73e-05	10	129	3	PS51263
Domain	ADF-H	DSTN CFL1 CFL2	3.73e-05	10	129	3	IPR002108
Domain	IGc2	FLT1 FLT4 SPEG MCAM IL1RAPL1 FGFR1 IL1RL1 FGFR2 IGSF1	3.75e-05	235	129	9	SM00408
Domain	Ig_sub2	FLT1 FLT4 SPEG MCAM IL1RAPL1 FGFR1 IL1RL1 FGFR2 IGSF1	3.75e-05	235	129	9	IPR003598
Domain	SPIN-2	SPIN2A SPIN2B	4.73e-05	2	129	2	IPR029564
Domain	Dynein_heavy_chain_D4_dom	DNAH7 DNAH6 DNAH11	1.11e-04	14	129	3	IPR024317
Domain	Dynein_HC_stalk	DNAH7 DNAH6 DNAH11	1.11e-04	14	129	3	IPR024743
Domain	Dynein_heavy_dom-2	DNAH7 DNAH6 DNAH11	1.11e-04	14	129	3	IPR013602
Domain	DHC_N2	DNAH7 DNAH6 DNAH11	1.11e-04	14	129	3	PF08393
Domain	MT	DNAH7 DNAH6 DNAH11	1.11e-04	14	129	3	PF12777
Domain	AAA_8	DNAH7 DNAH6 DNAH11	1.11e-04	14	129	3	PF12780
Domain	DHC_fam	DNAH7 DNAH6 DNAH11	1.38e-04	15	129	3	IPR026983
Domain	Dynein_heavy	DNAH7 DNAH6 DNAH11	1.38e-04	15	129	3	PF03028
Domain	Dynein_heavy_dom	DNAH7 DNAH6 DNAH11	1.38e-04	15	129	3	IPR004273
Domain	IG_LIKE	FLT1 FLT3 FLT4 SPEG MCAM IL1RAPL1 HHLA2 CD19 FGFR1 IL1RL1 FGFR2 IGSF1	1.54e-04	491	129	12	PS50835
Domain	Ig-like_dom	FLT1 FLT3 FLT4 SPEG MCAM IL1RAPL1 HHLA2 CD19 FGFR1 IL1RL1 FGFR2 IGSF1	1.93e-04	503	129	12	IPR007110
Domain	Pkinase_Tyr	FLT1 FLT3 FLT4 FGFR1 FGFR2 POMK	2.75e-04	129	129	6	PF07714
Domain	FGF_rcpt_fam	FGFR1 FGFR2	2.81e-04	4	129	2	IPR016248
Domain	Ig_I-set	FLT1 FLT4 SPEG IL1RAPL1 FGFR1 IL1RL1 FGFR2	3.55e-04	190	129	7	IPR013098
Domain	I-set	FLT1 FLT4 SPEG IL1RAPL1 FGFR1 IL1RL1 FGFR2	3.55e-04	190	129	7	PF07679
Domain	ig	FLT1 FLT3 FLT4 MCAM IL1RAPL1 FGFR1 IGSF1	3.55e-04	190	129	7	PF00047
Domain	Immunoglobulin	FLT1 FLT3 FLT4 MCAM IL1RAPL1 FGFR1 IGSF1	3.55e-04	190	129	7	IPR013151
Domain	Tyr_kinase_cat_dom	FLT1 FLT3 FLT4 FGFR1 FGFR2	3.60e-04	88	129	5	IPR020635
Domain	TyrKc	FLT1 FLT3 FLT4 FGFR1 FGFR2	3.60e-04	88	129	5	SM00219
Domain	Ser-Thr/Tyr_kinase_cat_dom	FLT1 FLT3 FLT4 FGFR1 FGFR2 POMK	3.94e-04	138	129	6	IPR001245
Domain	SPIN/Ssty	SPIN2A SPIN2B	4.67e-04	5	129	2	IPR003671
Domain	Spin-Ssty	SPIN2A SPIN2B	4.67e-04	5	129	2	PF02513
Domain	PROTEIN_KINASE_TYR	FLT1 FLT3 FLT4 FGFR1 FGFR2	5.64e-04	97	129	5	PS00109
Domain	Tyr_kinase_AS	FLT1 FLT3 FLT4 FGFR1 FGFR2	5.64e-04	97	129	5	IPR008266
Domain	-	DSTN CFL1 CFL2	5.86e-04	24	129	3	3.40.20.10
Domain	ADF-H/Gelsolin-like_dom	DSTN CFL1 CFL2	5.86e-04	24	129	3	IPR029006
Domain	Ser/Thr_kinase_AS	SPEG PAK5 LRRK2 STK38 MELK CDK10 CDK13 PRKCD CDK11B	8.44e-04	357	129	9	IPR008271
Domain	S_TKc	SPEG PAK5 LRRK2 STK38 MELK CDK10 CDK13 PRKCD CDK11B	8.78e-04	359	129	9	SM00220
Domain	PROTEIN_KINASE_ST	SPEG PAK5 LRRK2 STK38 MELK CDK10 CDK13 PRKCD CDK11B	9.31e-04	362	129	9	PS00108
Domain	Ca_chan_IQ	CACNA1A CACNA1E	9.72e-04	7	129	2	SM01062
Domain	Ca_chan_IQ	CACNA1A CACNA1E	9.72e-04	7	129	2	PF08763
Domain	VDCC_a1su_IQ	CACNA1A CACNA1E	9.72e-04	7	129	2	IPR014873
Domain	GPHH	CACNA1A CACNA1E	9.72e-04	7	129	2	PF16905
Domain	GPHH_dom	CACNA1A CACNA1E	9.72e-04	7	129	2	IPR031649
Domain	-	MOSPD2 TMEM131	1.29e-03	8	129	2	2.60.40.360
Domain	Pkinase	SPEG PAK5 LRRK2 STK38 MELK CDK10 CDK13 PRKCD CDK11B	1.33e-03	381	129	9	PF00069
Domain	PapD-like	MOSPD2 TMEM131	1.65e-03	9	129	2	IPR008962
Domain	VDCCAlpha1	CACNA1A CACNA1E	2.05e-03	10	129	2	IPR002077
Domain	IL-1_rcpt_fam	IL1RAPL1 IL1RL1	2.50e-03	11	129	2	IPR015621
Domain	FN3	SPEG IFNLR1 RIMBP3 RIMBP3C RIMBP3B IL23R	2.61e-03	199	129	6	PS50853
Domain	Homeobox_antennapedia	HOXA4 HOXD4	2.99e-03	12	129	2	IPR017995
Domain	SAM_2	DGKH SFMBT2 DLC1	3.25e-03	43	129	3	PF07647
Domain	AAA	ABCB7 ABCC11 DNAH7 DNAH6 DNAH11	3.26e-03	144	129	5	SM00382
Domain	AAA+_ATPase	ABCB7 ABCC11 DNAH7 DNAH6 DNAH11	3.26e-03	144	129	5	IPR003593
Domain	FN3_dom	SPEG IFNLR1 RIMBP3 RIMBP3C RIMBP3B IL23R	3.33e-03	209	129	6	IPR003961
Domain	Neurotransmitter_ion_chnl_CS	CHRNB2 GLRB GABRA4	3.70e-03	45	129	3	IPR018000
Domain	Neur_chan_memb	CHRNB2 GLRB GABRA4	3.93e-03	46	129	3	PF02932
Domain	ATPase_dyneun-rel_AAA	DNAH6 DNAH11	4.08e-03	14	129	2	IPR011704
Domain	AAA_5	DNAH6 DNAH11	4.08e-03	14	129	2	PF07728
Domain	Neurotrans-gated_channel_TM	CHRNB2 GLRB GABRA4	4.18e-03	47	129	3	IPR006029
Domain	-	CHRNB2 GLRB GABRA4	4.18e-03	47	129	3	2.70.170.10
Domain	Neur_chan_LBD	CHRNB2 GLRB GABRA4	4.18e-03	47	129	3	PF02931
Domain	NEUROTR_ION_CHANNEL	CHRNB2 GLRB GABRA4	4.18e-03	47	129	3	PS00236
Domain	Neur_channel	CHRNB2 GLRB GABRA4	4.18e-03	47	129	3	IPR006201
Domain	Neur_chan_lig-bd	CHRNB2 GLRB GABRA4	4.18e-03	47	129	3	IPR006202
Domain	-	PKP4 LRRK2 NCAPG2 PPP2R5C AP1B1 HEATR9	4.46e-03	222	129	6	1.25.10.10
Pathway	KEGG_MEDICUS_REFERENCE_REGULATION_OF_GF_RTK_RAS_ERK_SIGNALING_UBIQUITINATION_OF_RTK_BY_CBL	FLT1 FLT3 FLT4 FGFR1 FGFR2	5.08e-07	25	92	5	M47934
Pathway	WP_HIPPO_SIGNALING_REGULATION	FLT1 FLT3 FLT4 PRKCD PLCB2 FGFR1 FGFR2	3.42e-06	98	92	7	M39830
Pathway	REACTOME_NEGATIVE_REGULATION_OF_THE_PI3K_AKT_NETWORK	FLT3 PPP2R5C CD19 PIK3CA FGFR1 IL1RL1 FGFR2	1.17e-05	118	92	7	M713
Pathway	REACTOME_SIGNALING_BY_INSULIN_RECEPTOR	FLT3 IDE PIK3CA FGFR1 ATP6V1C2 FGFR2	1.54e-05	82	92	6	M1021
Pathway	KEGG_MEDICUS_REFERENCE_GF_RTK_PI3K_SIGNALING_PATHWAY	FLT1 FLT3 FLT4 PIK3CA FGFR1 FGFR2	1.65e-05	83	92	6	M47961
Pathway	KEGG_MEDICUS_VARIANT_AMPLIFIED_FGFR_TO_PI3K_SIGNALING_PATHWAY	PIK3CA FGFR1 FGFR2	2.20e-05	9	92	3	M47397
Pathway	KEGG_MEDICUS_REFERENCE_GF_RTK_RAS_PI3K_SIGNALING_PATHWAY	FLT1 FLT3 FLT4 PIK3CA FGFR1 FGFR2	2.46e-05	89	92	6	M47963
Pathway	WP_RAS_SIGNALING	FLT1 FLT3 FLT4 PAK5 PIK3CA PLA2G4A FGFR1 FGFR2	2.64e-05	184	92	8	M39764
Pathway	KEGG_MEDICUS_VARIANT_MUTATION_CAUSED_ABERRANT_SOD1_TO_RETROGRADE_AXONAL_TRANSPORT	DNAH7 DNAH17 DNAH6 DNAH11	2.66e-05	27	92	4	M47755
Pathway	WP_HIPPOMERLIN_SIGNALING_DYSREGULATION	FLT1 FLT3 FLT4 PAK5 FGFR1 FGFR2	1.38e-04	121	92	6	M39823
Pathway	KEGG_GLYCEROPHOSPHOLIPID_METABOLISM	AGPAT4 DGKH CHKA CHPT1 PLA2G4A	1.45e-04	77	92	5	M9131
Pathway	KEGG_MEDICUS_REFERENCE_RETROGRADE_AXONAL_TRANSPORT	DNAH7 DNAH17 DNAH6 DNAH11	1.73e-04	43	92	4	M47669
Pathway	SIG_CHEMOTAXIS	CFL1 CFL2 PAK5 PIK3CA	2.06e-04	45	92	4	M5193
Pathway	KEGG_MEDICUS_VARIANT_MUTATION_CAUSED_ABERRANT_HTT_TO_RETROGRADE_AXONAL_TRANSPORT	DNAH7 DNAH17 DNAH6 DNAH11	2.06e-04	45	92	4	M47670
Pathway	REACTOME_CONSTITUTIVE_SIGNALING_BY_ABERRANT_PI3K_IN_CANCER	FLT3 CD19 PIK3CA FGFR1 FGFR2	2.06e-04	83	92	5	M27163
Pathway	KEGG_TYPE_II_DIABETES_MELLITUS	CACNA1A CACNA1E PIK3CA PRKCD	2.44e-04	47	92	4	M19708
Pathway	REACTOME_IRS_MEDIATED_SIGNALLING	FLT3 PIK3CA FGFR1 FGFR2	2.65e-04	48	92	4	M26916
Pathway	KEGG_MEDICUS_REFERENCE_GF_RTK_RAS_ERK_SIGNALING_PATHWAY	FLT1 FLT3 FLT4 FGFR1 FGFR2	3.34e-04	92	92	5	M47927
Pathway	KEGG_FC_GAMMA_R_MEDIATED_PHAGOCYTOSIS	CFL1 CFL2 PIK3CA PLA2G4A PRKCD	4.06e-04	96	92	5	M16121
Pathway	REACTOME_SIGNALING_BY_TYPE_1_INSULIN_LIKE_GROWTH_FACTOR_1_RECEPTOR_IGF1R	FLT3 PIK3CA FGFR1 FGFR2	4.19e-04	54	92	4	M27168
Pathway	REACTOME_INSULIN_RECEPTOR_SIGNALLING_CASCADE	FLT3 PIK3CA FGFR1 FGFR2	4.19e-04	54	92	4	M620
Pathway	WP_REGULATION_OF_ACTIN_CYTOSKELETON	CFL1 CFL2 PAK5 PIK3CA FGFR1 FGFR2	4.41e-04	150	92	6	M39520
Pathway	KEGG_MEDICUS_REFERENCE_RTK_PLCG_ITPR_SIGNALING_PATHWAY	FLT1 FLT4 FGFR1 FGFR2	4.49e-04	55	92	4	M47952
Pathway	WP_REGULATION_OF_ACTIN_CYTOSKELETON	CFL1 CFL2 PAK5 PIK3CA FGFR1 FGFR2	4.73e-04	152	92	6	MM15834
Pathway	WP_ANGIOGENESIS	FLT1 PIK3CA FGFR2	4.93e-04	24	92	3	M39556
Pathway	BIOCARTA_VEGF_PATHWAY	FLT1 FLT4 PIK3CA	7.02e-04	27	92	3	M12975
Pathway	REACTOME_PI3K_AKT_SIGNALING_IN_CANCER	FLT3 CD19 PIK3CA FGFR1 FGFR2	7.57e-04	110	92	5	M27162
Pathway	REACTOME_SIGNALING_BY_RHO_GTPASES_MIRO_GTPASES_AND_RHOBTB3	MOSPD2 TEX2 CFL1 PKP4 PAK5 STK38 MCAM ECT2 PPP2R5C DLC1 PIK3CA PRKCD ZW10	7.72e-04	720	92	13	M41838
Pathway	REACTOME_NEGATIVE_REGULATION_OF_THE_PI3K_AKT_NETWORK	PPP2R5C CD19 PIK3CA FGFR1 IL1RL1	8.55e-04	113	92	5	MM14783
Pathway	REACTOME_INTRACELLULAR_SIGNALING_BY_SECOND_MESSENGERS	FLT3 PPP2R5C CD19 PIK3CA PRKCD FGFR1 IL1RL1 FGFR2	9.98e-04	313	92	8	M27867
Pathway	REACTOME_SIGNALING_BY_RHO_GTPASES_MIRO_GTPASES_AND_RHOBTB3	MOSPD2 TEX2 PKP4 PAK5 STK38 MCAM ECT2 PPP2R5C DLC1 PIK3CA PRKCD ZW10	1.02e-03	649	92	12	MM15690
Pathway	KEGG_MEDICUS_REFERENCE_FGF_FGFR_PI3K_SIGNALING_PATHWAY	PIK3CA FGFR1 FGFR2	1.06e-03	31	92	3	M47396
Pathway	REACTOME_GLYCEROPHOSPHOLIPID_BIOSYNTHESIS	ACP6 AGPAT4 CHKA CHPT1 PLA2G4A	1.12e-03	120	92	5	MM14585
Pathway	WP_MAPK_SIGNALING	CACNA1A CACNA1E LRRK2 PLA2G4A PRKCD FGFR1 FGFR2	1.12e-03	246	92	7	M39597
Pathway	REACTOME_VEGF_LIGAND_RECEPTOR_INTERACTIONS	FLT1 FLT4	1.15e-03	8	92	2	M710
Pathway	REACTOME_VEGF_LIGAND_RECEPTOR_INTERACTIONS	FLT1 FLT4	1.15e-03	8	92	2	MM14753
Pubmed	The three mouse actin-depolymerizing factor/cofilins evolved to fulfill cell-type-specific requirements for actin dynamics.	DSTN CFL1 CFL2	5.22e-08	3	131	3	11809832
Pubmed	TIRF microscopy analysis of human Cof1, Cof2, and ADF effects on actin filament severing and turnover.	DSTN CFL1 CFL2	5.22e-08	3	131	3	26996939
Pubmed	Paralog knockout profiling identifies DUSP4 and DUSP6 as a digenic dependence in MAPK pathway-driven cancers.	DMXL2 DSTN CFL1 STK38 DGKH KAT2A CDK10 PPP2R5C AP1B1 CDK13 DNAH17 PRKCD PLCB2 CDK11B DNAH11	1.18e-07	730	131	15	34857952
Pubmed	Identification of dynein heavy chain genes expressed in human and mouse testis: chromosomal localization of an axonemal dynein gene.	DNAH7 DNAH17 DNAH6 DNAH11	1.87e-07	14	131	4	9373155
Pubmed	Integrin activation is required for VEGF and FGF receptor protein presence on human microvascular endothelial cells.	FLT1 FGFR1 FGFR2	2.08e-07	4	131	3	11693202
Pubmed	PCR-based identification of new receptors: molecular cloning of a receptor for fibroblast growth factors.	FLT1 FGFR1 FGFR2	2.08e-07	4	131	3	1711190
Pubmed	ADF/Cofilin-Mediated Actin Turnover Promotes Axon Regeneration in the Adult CNS.	DSTN CFL1 CFL2	2.08e-07	4	131	3	31400829
Pubmed	RIM-BP3 is a manchette-associated protein essential for spermiogenesis.	RIMBP3 RIMBP3C RIMBP3B	2.08e-07	4	131	3	19091768
Pubmed	Fibroblast growth factor signals regulate a wave of Hedgehog activation that is essential for coronary vascular development.	FLT1 FLT4 FGFR1 FGFR2	4.40e-07	17	131	4	16778080
Pubmed	Distinct association of genetic variations of vascular endothelial growth factor, transforming growth factor-beta, and fibroblast growth factor receptors with atopy and airway hyperresponsiveness.	FLT1 FGFR1 FGFR2	5.19e-07	5	131	3	18315732
Pubmed	Structure and evolution of RIM-BP genes: identification of a novel family member.	RIMBP3 RIMBP3C RIMBP3B	5.19e-07	5	131	3	17855024
Pubmed	Novel tool to suppress cell proliferation in vivo demonstrates that myocardial and coronary vascular growth represent distinct developmental programs.	FLT1 FGFR1 FGFR2	2.88e-06	8	131	3	18297725
Pubmed	Novel splice variants derived from the receptor tyrosine kinase superfamily are potential therapeutics for rheumatoid arthritis.	FLT1 FLT4 FGFR1 FGFR2	3.67e-06	28	131	4	18593464
Pubmed	Stimulation of phosphatidylinositol 3-kinase by fibroblast growth factor receptors is mediated by coordinated recruitment of multiple docking proteins.	PIK3CA FGFR1 FGFR2	4.31e-06	9	131	3	11353842
Pubmed	The diminished expression of proangiogenic growth factors and their receptors in gastric ulcers of cirrhotic patients.	FLT1 FGFR1 FGFR2	4.31e-06	9	131	3	23620752
Pubmed	ADF/cofilin-mediated actin retrograde flow directs neurite formation in the developing brain.	DSTN CFL1 CFL2	6.15e-06	10	131	3	23259946
Pubmed	Malignant progressive tumor cell clone exhibits significant up-regulation of cofilin-2 and 27-kDa modified form of cofilin-1 compared to regressive clone.	CFL1 CFL2	1.41e-05	2	131	2	24023293
Pubmed	Determining the differences in actin binding by human ADF and cofilin.	DSTN CFL1	1.41e-05	2	131	2	11812157
Pubmed	Structural and functional diversity in the FGF receptor multigene family.	FGFR1 FGFR2	1.41e-05	2	131	2	8417497
Pubmed	Molecular cloning of murine FLT and FLT4.	FLT1 FLT4	1.41e-05	2	131	2	8393164
Pubmed	Facial suture synostosis of newborn Fgfr1(P250R/+) and Fgfr2(S252W/+) mouse models of Pfeiffer and Apert syndromes.	FGFR1 FGFR2	1.41e-05	2	131	2	21538817
Pubmed	Mapping of human non-muscle type cofilin (CFL1) to chromosome 11q13 and muscle-type cofilin (CFL2) to chromosome 14.	CFL1 CFL2	1.41e-05	2	131	2	8800436
Pubmed	Bad bones, absent smell, selfish testes: the pleiotropic consequences of human FGF receptor mutations.	FGFR1 FGFR2	1.41e-05	2	131	2	15863034
Pubmed	Fibroblast Growth Factor Signaling Mediates Pulmonary Endothelial Glycocalyx Reconstitution.	FGFR1 FGFR2	1.41e-05	2	131	2	28187268
Pubmed	Correlation of DLC1 gene methylation with oncogenic PIK3CA mutations in extramammary Paget's disease.	DLC1 PIK3CA	1.41e-05	2	131	2	22522847
Pubmed	The human fibroblast growth factor receptor genes: a common structural arrangement underlies the mechanisms for generating receptor forms that differ in their third immunoglobulin domain.	FGFR1 FGFR2	1.41e-05	2	131	2	1652059
Pubmed	Fibroblast growth factor receptors 1 and 2 in keratinocytes control the epidermal barrier and cutaneous homeostasis.	FGFR1 FGFR2	1.41e-05	2	131	2	20308431
Pubmed	Protein kinase Cδ is essential for the IgG response against T-cell-independent type 2 antigens and commensal bacteria.	CD19 PRKCD	1.41e-05	2	131	2	34693907
Pubmed	Distinct roles of fibroblast growth factor receptor 1 and 2 in regulating cell survival and epithelial-mesenchymal transition.	FGFR1 FGFR2	1.41e-05	2	131	2	17284663
Pubmed	Spatial distribution and functional relevance of FGFR1 and FGFR2 expression for glioblastoma tumor invasion.	FGFR1 FGFR2	1.41e-05	2	131	2	37579831
Pubmed	Spontaneous corneal hem- and lymphangiogenesis in mice with destrin-mutation depend on VEGFR3 signaling.	FLT4 DSTN	1.41e-05	2	131	2	15855638
Pubmed	A pathway involving protein kinase Cdelta up-regulates cytosolic phospholipase A(2)alpha in airway epithelium.	PLA2G4A PRKCD	1.41e-05	2	131	2	15358156
Pubmed	Aberrant FGFR signaling mediates resistance to CDK4/6 inhibitors in ER+ breast cancer.	FGFR1 FGFR2	1.41e-05	2	131	2	30914635
Pubmed	Developmental expression of two murine fibroblast growth factor receptors, flg and bek.	FGFR1 FGFR2	1.41e-05	2	131	2	1667382
Pubmed	Cofilin hyperactivation in HIV infection and targeting the cofilin pathway using an anti-α4β7 integrin antibody.	CFL1 CFL2	1.41e-05	2	131	2	30662943
Pubmed	Prognostic value of FGFR gene amplification in patients with different types of cancer: a systematic review and meta-analysis.	FGFR1 FGFR2	1.41e-05	2	131	2	25171497
Pubmed	The histone lysine methyltransferase KMT2D sustains a gene expression program that represses B cell lymphoma development.	KMT2D CD19	1.41e-05	2	131	2	26366710
Pubmed	Distinct sets of FGF receptors sculpt excitatory and inhibitory synaptogenesis.	FGFR1 FGFR2	1.41e-05	2	131	2	25926357
Pubmed	Immunolocalization of fibroblast growth factor receptors 1 and 2 in mouse palate development.	FGFR1 FGFR2	1.41e-05	2	131	2	11391199
Pubmed	Blocking Fibroblast Growth Factor receptor signaling inhibits tumor growth, lymphangiogenesis, and metastasis.	FLT4 FGFR1	1.41e-05	2	131	2	22761819
Pubmed	Paracrine interactions through FGFR1 and FGFR2 receptors regulate the development of preimplantation mouse chimaeric embryo.	FGFR1 FGFR2	1.41e-05	2	131	2	36382369
Pubmed	The fibroblast growth factor receptors, FGFR-1 and FGFR-2, mediate two independent signalling pathways in human retinal pigment epithelial cells.	FGFR1 FGFR2	1.41e-05	2	131	2	16188231
Pubmed	Conserved use of a non-canonical 5' splice site (/GA) in alternative splicing by fibroblast growth factor receptors 1, 2 and 3.	FGFR1 FGFR2	1.41e-05	2	131	2	9499422
Pubmed	Inhibition of cellular senescence by developmentally regulated FGF receptors in mesenchymal stem cells.	FGFR1 FGFR2	1.41e-05	2	131	2	21527526
Pubmed	Proteomic profiling identifies an UV-induced activation of cofilin-1 and destrin in human epidermis.	DSTN CFL1	1.41e-05	2	131	2	15816841
Pubmed	FGFR1 and FGFR2 mutations in Pfeiffer syndrome.	FGFR1 FGFR2	1.41e-05	2	131	2	23348274
Pubmed	Loss of Fgfr1 and Fgfr2 in Scleraxis-lineage cells leads to enlarged bone eminences and attachment cell death.	FGFR1 FGFR2	1.41e-05	2	131	2	37212424
Pubmed	Characterization of a novel cofilin isoform that is predominantly expressed in mammalian skeletal muscle.	CFL1 CFL2	1.41e-05	2	131	2	8195165
Pubmed	ADF and Cofilin1 Control Actin Stress Fibers, Nuclear Integrity, and Cell Survival.	DSTN CFL1	1.41e-05	2	131	2	26655907
Pubmed	Two FGF receptor genes are differentially expressed in epithelial and mesenchymal tissues during limb formation and organogenesis in the mouse.	FGFR1 FGFR2	1.41e-05	2	131	2	1315677
Pubmed	FGFR1 down-regulation in differentiating human brain and spinal cord neurospheres.	FGFR1 FGFR2	1.41e-05	2	131	2	15618886
Pubmed	Differential expression of up-regulated cofilin-1 and down-regulated cofilin-2 characteristic of pancreatic cancer tissues.	CFL1 CFL2	1.41e-05	2	131	2	21894436
Pubmed	Conditional activation of fibroblast growth factor receptor (FGFR) 1, but not FGFR2, in prostate cancer cells leads to increased osteopontin induction, extracellular signal-regulated kinase activation, and in vivo proliferation.	FGFR1 FGFR2	1.41e-05	2	131	2	14559809
Pubmed	Compensatory contribution of Cav2.3 channels to acetylcholine release at the neuromuscular junction of tottering mice.	CACNA1A CACNA1E	1.41e-05	2	131	2	16381801
Pubmed	Neurokinin 1 receptors trigger overlapping stimulation and inhibition of CaV2.3 (R-type) calcium channels.	CACNA1E TACR1	1.41e-05	2	131	2	17050807
Pubmed	Involvement of fibroblast growth factor receptor genes in benign prostate hyperplasia in a Korean population.	FGFR1 FGFR2	1.41e-05	2	131	2	24385678
Pubmed	ADF and cofilin-1 collaborate to promote cortical actin flow and the leader bleb-based migration of confined cells.	DSTN CFL1	1.41e-05	2	131	2	34169836
Pubmed	FGFR1 and FGFR2 in fibrolamellar carcinoma.	FGFR1 FGFR2	1.41e-05	2	131	2	26259677
Pubmed	Genomic profiling of malignant phyllodes tumors reveals aberrations in FGFR1 and PI-3 kinase/RAS signaling pathways and provides insights into intratumoral heterogeneity.	PIK3CA FGFR1	1.41e-05	2	131	2	27255162
Pubmed	N-cofilin can compensate for the loss of ADF in excitatory synapses.	DSTN CFL1	1.41e-05	2	131	2	22046357
Pubmed	PI 3-Kinase and the Histone Methyl-Transferase KMT2D Collaborate to Induce Arp2/3-Dependent Migration of Mammary Epithelial Cells.	KMT2D PIK3CA	1.41e-05	2	131	2	38786098
Pubmed	Fibroblast growth factor receptor signalling has a role in lobuloalveolar development of the mammary gland.	FGFR1 FGFR2	1.41e-05	2	131	2	9202386
Pubmed	FGF signaling in the osteoprogenitor lineage non-autonomously regulates postnatal chondrocyte proliferation and skeletal growth.	FGFR1 FGFR2	1.41e-05	2	131	2	27052727
Pubmed	FGF receptors 1 and 2 control chemically induced injury and compound detoxification in regenerating livers of mice.	FGFR1 FGFR2	1.41e-05	2	131	2	20603121
Pubmed	Overexpression of fibroblast growth factor receptors FGFR1 and FGFR2 in renal cell carcinoma.	FGFR1 FGFR2	1.41e-05	2	131	2	21329481
Pubmed	Accumulation and activation of epidermal γδ T cells in a mouse model of chronic dermatitis is not required for the inflammatory phenotype.	FGFR1 FGFR2	1.41e-05	2	131	2	26081170
Pubmed	Expression of basic fibroblast growth factor, FGFR1 and FGFR2 in normal and malignant human breast, and comparison with other normal tissues.	FGFR1 FGFR2	1.41e-05	2	131	2	1380281
Pubmed	The ADF/cofilin proteins: stimulus-responsive modulators of actin dynamics.	CFL1 CFL2	1.41e-05	2	131	2	8589446
Pubmed	Mapping the ADF/cofilin binding site on monomeric actin by competitive cross-linking and peptide array: evidence for a second binding site on monomeric actin.	DSTN CFL1	1.41e-05	2	131	2	17196218
Pubmed	Epigenetically controlled fibroblast growth factor receptor 2 signaling imposes on the RAS/BRAF/mitogen-activated protein kinase pathway to modulate thyroid cancer progression.	FGFR1 FGFR2	1.41e-05	2	131	2	17545628
Pubmed	Functional cloning of SPIN-2, a nuclear anti-apoptotic protein with roles in cell cycle progression.	SPIN2A SPIN2B	1.41e-05	2	131	2	12145692
Pubmed	Solution structure of human cofilin: actin binding, pH sensitivity, and relationship to actin-depolymerizing factor.	DSTN CFL1	1.41e-05	2	131	2	14627701
Pubmed	The ADF/cofilin family: actin-remodeling proteins.	CFL1 CFL2	1.41e-05	2	131	2	12049672
Pubmed	Differential involvement of destrin and cofilin-1 in the control of invasive properties of Isreco1 human colon cancer cells.	DSTN CFL1	1.41e-05	2	131	2	17583572
Pubmed	Chromosomal localization of FLT4, a novel receptor-type tyrosine kinase gene.	FLT3 FLT4	1.41e-05	2	131	2	1319394
Pubmed	Upper extremity anomalies in Pfeiffer syndrome and mutational correlations.	FGFR1 FGFR2	1.41e-05	2	131	2	24776567
Pubmed	FGF receptors 1 and 2 are key regulators of keratinocyte migration in vitro and in wounded skin.	FGFR1 FGFR2	1.41e-05	2	131	2	22992463
Pubmed	Targeted expression of a dominant negative FGF receptor blocks branching morphogenesis and epithelial differentiation of the mouse lung.	FGFR1 FGFR2	1.41e-05	2	131	2	8045260
Pubmed	The neural cell adhesion molecule binds to fibroblast growth factor receptor 2.	FGFR1 FGFR2	1.41e-05	2	131	2	16709412
Pubmed	Targeting promiscuous heterodimerization overcomes innate resistance to ERBB2 dimerization inhibitors in breast cancer.	FLT3 FLT4 FGFR1 FGFR2	1.58e-05	40	131	4	30898150
Pubmed	The protein tyrosine kinase family of the human genome.	FLT1 FLT3 FLT4 FGFR1 FGFR2	1.61e-05	83	131	5	11114734
Pubmed	Integrative characterization of germ cell-specific genes from mouse spermatocyte UniGene library.	RIMBP3 RIMBP3C RIMBP3B	1.84e-05	14	131	3	17662146
Pubmed	Severe protein aggregate myopathy in a knockout mouse model points to an essential role of cofilin2 in sarcomeric actin exchange and muscle maintenance.	DSTN CFL1 CFL2	2.30e-05	15	131	3	24598388
Pubmed	Clarifying the role of G protein signaling in HIV infection: new approaches to an old question.	CFL1 CFL2 PLCB2	2.82e-05	16	131	3	20842205
Pubmed	Loss of endogenous thymosin β4 accelerates glomerular disease.	DSTN CFL1 CFL2	4.09e-05	18	131	3	27575556
Pubmed	Ggnbp2 Is Essential for Pregnancy Success via Regulation of Mouse Trophoblast Stem Cell Proliferation and Differentiation.	FLT1 FLT4 FGFR1 FGFR2	4.19e-05	51	131	4	26764350
Pubmed	Rosette-forming glioneuronal tumors share a distinct DNA methylation profile and mutations in FGFR1, with recurrent co-mutation of PIK3CA and NF1.	PIK3CA FGFR1	4.21e-05	3	131	2	31250151
Pubmed	Transient Redirection of SVZ Stem Cells to Oligodendrogenesis by FGFR3 Activation Promotes Remyelination.	FGFR1 FGFR2	4.21e-05	3	131	2	31189094
Pubmed	Loss of PTEN induces microtentacles through PI3K-independent activation of cofilin.	CFL1 PIK3CA	4.21e-05	3	131	2	22689060
Pubmed	Vascular endothelial growth factor receptors 1,3 and caveolin-1 are implicated in colorectal cancer aggressiveness and prognosis--correlations with epidermal growth factor receptor, CD44v6, focal adhesion kinase, and c-Met.	FLT1 FLT4	4.21e-05	3	131	2	23580180
Pubmed	Different clinical significance of FGFR1-4 expression between diffuse-type and intestinal-type gastric cancer.	FGFR1 FGFR2	4.21e-05	3	131	2	28056982
Pubmed	Early endocardial morphogenesis requires Scl/Tal1.	FLT1 FLT4	4.21e-05	3	131	2	17722983
Pubmed	Isolation of the complementary DNA encoding a mouse heparin-binding growth factor receptor with the use of a unique kinase insert sequence.	FGFR1 FGFR2	4.21e-05	3	131	2	8382556
Pubmed	Dephosphorylation of serine 3 regulates nuclear translocation of cofilin.	CFL1 CFL2	4.21e-05	3	131	2	8824278
Pubmed	The genomic landscape and evolution of endometrial carcinoma progression and abdominopelvic metastasis.	PIK3CA FGFR2	4.21e-05	3	131	2	27348297
Pubmed	Fibroblast growth factor receptor signaling in pediatric B-cell precursor acute lymphoblastic leukemia.	FGFR1 FGFR2	4.21e-05	3	131	2	30755670
Pubmed	A truncated derivative of FGFR1 kinase cooperates with FLT3 and KIT to transform hematopoietic stem cells in syndromic and de novo AML.	FLT3 FGFR1	4.21e-05	3	131	2	35906694
Pubmed	Development of covalent inhibitors that can overcome resistance to first-generation FGFR kinase inhibitors.	FGFR1 FGFR2	4.21e-05	3	131	2	25349422
Pubmed	BMP-2 differentially modulates FGF-2 isoform effects in osteoblasts from newborn transgenic mice.	FGFR1 FGFR2	4.21e-05	3	131	2	23715864
Pubmed	Actin-Depolymerizing Factor and Cofilin-1 Have Unique and Overlapping Functions in Regulating Intestinal Epithelial Junctions and Mucosal Inflammation.	DSTN CFL1	4.21e-05	3	131	2	26878213
Cytoband	Xp11.1	SPIN2A SPIN2B	4.83e-05	4	131	2	Xp11.1
GeneFamily	Dyneins, axonemal	DNAH7 DNAH17 DNAH6 DNAH11	1.19e-06	17	88	4	536
GeneFamily	Receptor Tyrosine Kinases\|CD molecules	FLT1 FLT3 FLT4 FGFR1 FGFR2	1.40e-06	40	88	5	321
GeneFamily	Immunoglobulin like domain containing	FLT1 FLT3 FLT4 MCAM IL1RAPL1 CD19 IL1RL1 IGSF1	4.52e-06	193	88	8	594
GeneFamily	Blood group antigens\|CD molecules\|I-set domain containing\|Immunoglobulin like domain containing	FLT1 FLT4 SPEG IL1RAPL1 FGFR1 IL1RL1 FGFR2	1.35e-05	161	88	7	593
GeneFamily	Tudor domain containing\|Spindlin family	SPIN2A SPIN2B	2.32e-04	5	88	2	1089
GeneFamily	Cyclin dependent kinases	CDK10 CDK13 CDK11B	2.67e-04	26	88	3	496
GeneFamily	CD molecules\|I-set domain containing\|Immunoglobulin like domain containing\|Interleukin receptors\|TIR domain containing	IL1RAPL1 IL1RL1	2.36e-03	15	88	2	1296
GeneFamily	Phospholipases\|C2 domain containing phospholipases	PLA2G4A PLCB2	3.80e-03	19	88	2	832
Coexpression	GSE5589_LPS_VS_LPS_AND_IL6_STIM_IL6_KO_MACROPHAGE_45MIN_DN	DMXL2 AGPAT4 REV3L FRMD4A RPUSD4 CHPT1 PLCB2 FILIP1L	7.32e-06	200	130	8	M6621
ToppCell	Adult-Epithelial-ciliated_cell-D175\|Adult / Lineage, Cell type, age group and donor	CFAP47 DNAH7 ADGB HHLA2 CFAP77 SLFN13 DNAH6 DNAH11	7.89e-08	185	131	8	30f4980dee6cd5959655f8d74049f3bfb5312611
ToppCell	Fetal_29-31_weeks-Epithelial-ciliated_cell-D062\|Fetal_29-31_weeks / Lineage, Cell type, age group and donor	CFAP47 DNAH7 ADGB HHLA2 CFAP77 DNAH6 DNAH11	9.95e-07	178	131	7	de5d50d7ca9ee9eb62f50c88a0c6d47f0694b2e6
ToppCell	Fetal_29-31_weeks-Epithelial-ciliated_cell-D088\|Fetal_29-31_weeks / Lineage, Cell type, age group and donor	CFAP47 DNAH7 ADGB HHLA2 CFAP77 DNAH6 DNAH11	1.11e-06	181	131	7	dfce05bd472f67e6e2bb60ebd6fd34f0a9aeeca6
ToppCell	Adult-Epithelial-ciliated_cell-D122\|Adult / Lineage, Cell type, age group and donor	CFAP47 DNAH7 ADGB HHLA2 CFAP77 DNAH6 DNAH11	1.15e-06	182	131	7	7ded554a4b441e6496db673ba206c0d76ccad7d9
ToppCell	Children_(3_yrs)-Epithelial-ciliated_cell-D139\|Children_(3_yrs) / Lineage, Cell type, age group and donor	CFAP47 DNAH7 ADGB HHLA2 CFAP77 DNAH6 DNAH11	1.24e-06	184	131	7	5daff849625f2f41d56615569c0ed59cd733b34c
ToppCell	Fetal_29-31_weeks-Epithelial-ciliated_cell-D150\|Fetal_29-31_weeks / Lineage, Cell type, age group and donor	CFAP47 DNAH7 ADGB HHLA2 CFAP77 DNAH6 DNAH11	1.29e-06	185	131	7	3e39a3cb534dfe2301930f3e2f7e8cefb522c158
ToppCell	COVID-19-Epithelial_cells-Airway_ciliated\|COVID-19 / group, cell type (main and fine annotations)	CFAP47 DNAH7 ADGB HHLA2 CFAP77 DNAH6 DNAH11	1.29e-06	185	131	7	18a40f0a338aa398d81384b5159fb80ce8a2020c
ToppCell	Fetal_29-31_weeks-Epithelial-ciliated_cell\|Fetal_29-31_weeks / Lineage, Cell type, age group and donor	CFAP47 DNAH7 ADGB HHLA2 CFAP77 DNAH6 DNAH11	1.38e-06	187	131	7	9e10ed56090d82589bc457788282f664b70ace4b
ToppCell	Epithelial-ciliated_cell\|World / Lineage, Cell type, age group and donor	CFAP47 DNAH7 ADGB HHLA2 CFAP77 DNAH6 DNAH11	1.43e-06	188	131	7	61a459f3fe57e5728efc72637ff2edc2d343492b
ToppCell	Adult-Epithelial-ciliated_cell-D231\|Adult / Lineage, Cell type, age group and donor	CFAP47 DNAH7 ADGB HHLA2 CFAP77 DNAH6 DNAH11	1.43e-06	188	131	7	34b11f72ca73153d02edcd09b38983ad1a504659
ToppCell	Children_(3_yrs)-Epithelial-ciliated_cell\|Children_(3_yrs) / Lineage, Cell type, age group and donor	CFAP47 DNAH7 ADGB HHLA2 CFAP77 DNAH6 DNAH11	1.43e-06	188	131	7	2b6dfc88be9ded7b88da9fe78a9cd9f9b3af8af3
ToppCell	COVID-19-lung-Ciliated\|COVID-19 / Disease (COVID-19 only), tissue and cell type	CFAP47 DNAH7 ADGB HHLA2 CFAP77 DNAH6 DNAH11	1.49e-06	189	131	7	a2da5debd10f27b1280b40141ef0bfef007cc72c
ToppCell	Children_(3_yrs)-Epithelial-ciliated_cell-D032\|Children_(3_yrs) / Lineage, Cell type, age group and donor	CFAP47 DNAH7 ADGB HHLA2 CFAP77 DNAH6 DNAH11	1.49e-06	189	131	7	68a3cf7763d6f9b95d6d6524eff7a16042703f1d
ToppCell	Adult-Epithelial-ciliated_cell\|Adult / Lineage, Cell type, age group and donor	CFAP47 DNAH7 ADGB HHLA2 CFAP77 DNAH6 DNAH11	1.49e-06	189	131	7	b679920f0993e917dd86da082113bfbd85ea1ca5
ToppCell	COVID-19-lung-Ciliated\|lung / Disease (COVID-19 only), tissue and cell type	CFAP47 DNAH7 ADGB HHLA2 CFAP77 DNAH6 DNAH11	1.49e-06	189	131	7	27329c4661aebabd19fac7fe5dca263fe99d76f3
ToppCell	nucseq-Epithelial-Epithelial_Airway-Ciliated/Deuterosomal-Ciliated\|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2	CFAP47 DNAH7 ADGB HHLA2 CFAP77 DNAH6 DNAH11	1.59e-06	191	131	7	e417bf491f8b8d7838a61f7f4f6b1740ba97aa3f
ToppCell	nucseq-Epithelial-Epithelial_Airway-Ciliated/Deuterosomal\|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2	CFAP47 DNAH7 ADGB HHLA2 CFAP77 DNAH6 DNAH11	1.59e-06	191	131	7	9d31c8424d35bdc0c27188b68bfd0f731af3600b
ToppCell	nucseq-Epithelial-Epithelial_Airway\|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2	CFAP47 DNAH7 ADGB HHLA2 CFAP77 DNAH6 DNAH11	1.59e-06	191	131	7	1c528f72c9ef3ef3a850b05e4a9715190832270c
ToppCell	human_hepatoblastoma-Endothelial_cells\|human_hepatoblastoma / Sample and Cell Type and Tumor Cluster (all cells)	FLT1 FLT4 TMEM233 MCAM DGKH SFMBT2 ADGRL2	1.65e-06	192	131	7	e09f609fed033a25baacaf4a07bbbae1076da366
ToppCell	IPF-Epithelial-Ciliated\|World / Disease state, Lineage and Cell class	CFAP47 DNAH7 ADGB HHLA2 CFAP77 DNAH6 DNAH11	1.65e-06	192	131	7	d903bbd6c18e29e2c4cdedeb3fea1fd5ad7baa11
ToppCell	3'-Parenchyma_lung-Epithelial-Airway_ciliated-ciliated_columnar_cell_of_tracheobronchial_tree-Multiciliated_(non-nasal)-Multiciliated_(non-nasal)_L.0.3.2.3\|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	CFAP47 LRRK2 STEAP4 DNAH7 CFAP77 DNAH6 DNAH11	1.71e-06	193	131	7	bdb7401dd9059032f930f2b575f2ef8e504b6594
ToppCell	Control-Epithelial-Ciliated\|World / Disease state, Lineage and Cell class	CFAP47 DNAH7 ADGB HHLA2 CFAP77 DNAH6 DNAH11	1.77e-06	194	131	7	958e648138676d46698090b4046cb484083ae449
ToppCell	wk_15-18-Epithelial-Proximal_epithelial\|wk_15-18 / Celltypes from embryonic and fetal-stage human lung	CFAP47 DNAH7 ADGB HHLA2 CFAP77 DNAH6 DNAH11	1.77e-06	194	131	7	b0477583301dc6d9767b667bd2f8f94fbfaa6f81
ToppCell	3'-Broncho-tracheal-Epithelial-Airway_ciliated-ciliated_columnar_cell_of_tracheobronchial_tree-Multiciliated_(non-nasal)-Multiciliated_(non-nasal)_L.0.3.3.0\|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	CFAP47 INTU DNAH7 ADGB SLFN13 DNAH6 DNAH11	1.77e-06	194	131	7	4a2c127c90d1fefe604fcb9e796577d21b489dd6
ToppCell	wk_15-18-Epithelial-Proximal_epithelial-Ciliated\|wk_15-18 / Celltypes from embryonic and fetal-stage human lung	CFAP47 DNAH7 ADGB HHLA2 CFAP77 DNAH6 DNAH11	1.83e-06	195	131	7	cfcf554b436083179dea1d6fd6e3a800ea2430fe
ToppCell	background-Endothelial_cells\|background / Sample and Cell Type and Tumor Cluster (all cells)	FLT1 FLT4 SLC26A5 MCAM SFMBT2 FGFR1 ADGRL2	1.89e-06	196	131	7	e6fb0bfab1779ec64a8c35d01519eaafbf62e977
ToppCell	3'-Parenchyma_lung-Epithelial-Airway_ciliated-ciliated_columnar_cell_of_tracheobronchial_tree-Multiciliated_(non-nasal)-Multiciliated_(non-nasal)_L.0.3.2.2\|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	CFAP47 INTU DNAH7 ADGB HHLA2 DNAH6 DNAH11	1.96e-06	197	131	7	74a2c6cb8fcfe53dd9a2b36492a16c58f38e51c9
ToppCell	Primary_Motor_Cortex_(M1)-Neuronal\|Primary_Motor_Cortex_(M1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types	MYT1L CACNA1A PAK5 FRMD4A GLRB ADGRL2 GABRA4	2.02e-06	198	131	7	4ca5ff320905ab4ff60ed90a5522227c782142a6
ToppCell	Biopsy_Other_PF-Epithelial-Differentiating_Ciliated\|Biopsy_Other_PF / Sample group, Lineage and Cell type	CFAP47 DNAH7 ADGB HHLA2 CFAP77 DNAH6 DNAH11	2.16e-06	200	131	7	f7b4581d958afbd68f9045af619aaca0ab463439
ToppCell	LPS_only-Endothelial-Endothelial-Activated_Gen_Cap\|LPS_only / Treatment groups by lineage, cell group, cell type	FLT1 SPTLC2 PKP4 PARP14 DLC1 ADGRL2 FILIP1L	2.16e-06	200	131	7	6f531a418ff25b59a543800cf4bce7b72404ce08
ToppCell	Lung_Parenchyma-Control-Epithelial-Epithelial-Ciliated\|Control / Location, Disease Group, Cell group, Cell class (2021.03.09)	CFAP47 DNAH7 ADGB HHLA2 CFAP77 DNAH6 DNAH11	2.16e-06	200	131	7	ddd39b754bfaa98249d497dfb7e97ec58617a11a
ToppCell	Parenchyma_Control_(B.)-Epithelial-TX-Ciliated\|Parenchyma_Control_(B.) / Sample group, Lineage and Cell type	CFAP47 DNAH7 ADGB HHLA2 CFAP77 DNAH6 DNAH11	2.16e-06	200	131	7	a521cf837cadf280505ff9d7e641a205af7d6513
ToppCell	Lung_Parenchyma-Control-Epithelial-Epithelial-Ciliated-\|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)	CFAP47 DNAH7 ADGB HHLA2 CFAP77 DNAH6 DNAH11	2.16e-06	200	131	7	918b576fd9491d23c2bb9d663fa5fb3505cb1c7e
ToppCell	LPS-IL1RA+antiTNF-Epithelial_airway-Ciliated_cells\|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	DNAH7 ADGB CFAP77 HEATR9 DNAH6 DNAH11	6.65e-06	155	131	6	5f1e2195a6b831e1b636f5cc3a282ca423721822
ToppCell	LPS-IL1RA+antiTNF-Epithelial_airway-Ciliated_cells-Ciliated\|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	DNAH7 ADGB CFAP77 HEATR9 DNAH6 DNAH11	6.65e-06	155	131	6	0944429459f642a1bcc56edc1ec28aaecde3e2dc
ToppCell	10x_3'_v2v3-Non-neoplastic-Glial-Neuronal-OPC-OPC-E\|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group	CACNA1A ABHD2 APOD PKDREJ GLRB HFM1	6.65e-06	155	131	6	77fdae85d36efb776db977eb424b32487ef222e4
ToppCell	NS-moderate-d_07-13-Epithelial-FOXN4+\|d_07-13 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined)	CFAP47 INTU MELK DNAH7 DNAH6 DNAH11	7.16e-06	157	131	6	410c9d74a2085179cfb39853cb6d330fa98c9c1b
ToppCell	343B-Lymphocytic-NK_cells-NK_cell_D2\|Lymphocytic / Donor, Lineage, Cell class and subclass (all cells)	TRPM4 INTU FLT4 CHKA DHX32 IL1RL1	7.42e-06	158	131	6	74aa4f75307575ac3b2b1aa9f727753692f88742
ToppCell	droplet-Liver-LIVER_HEP-30m-Myeloid-myeloid_leukocyte\|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	FLT3 LRRK2 AGPAT4 MELK IFNLR1 SMPDL3B	7.42e-06	158	131	6	91d265e95156f16459924d3e4dd11c180e164eee
ToppCell	Ciliated_cells-A-Donor_01\|World / lung cells shred on cell class, cell subclass, sample id	APOD DNAH7 ADGB HHLA2 CFAP77 DNAH11	8.87e-06	163	131	6	43194c6127df1ce3d29242f719645de3c11fd7c0
ToppCell	Ciliated_cells-B-Donor_03\|World / lung cells shred on cell class, cell subclass, sample id	CFAP47 DNAH7 ADGB HHLA2 CFAP77 DNAH11	9.18e-06	164	131	6	fd30c55d0d75ef8b9396435d836187168095152b
ToppCell	Smart-start-Cell-Wel_seq-Non-neoplastic-Myeloid-TAM-MG\|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group	CACNA1A SFMBT2 FRMD4A RNASET2 PRKCD PLCB2	1.02e-05	167	131	6	942134bbabe9972fae80cbc4ed4e94da52f55dc3
ToppCell	3'-Broncho-tracheal-Epithelial-Airway_ciliated-ciliated_columnar_cell_of_tracheobronchial_tree-Multiciliated_(non-nasal)-Multiciliated_(non-nasal)_L.0.3.0.2\|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	INTU DGKH DNAH7 ADGB DNAH6 DNAH11	1.09e-05	169	131	6	14aadc2d1bf66eb47dac33b4d61ddb3c942caa4f
ToppCell	3'_v3-GI_small-bowel-Mast-Mast_cell_granulo-myelo\|GI_small-bowel / Manually curated celltypes from each tissue	TMEM233 IL1RAPL1 DLC1 IL1RL1 FGFR2 FILIP1L	1.20e-05	172	131	6	3df11aefc09762fd1f94441324551178e030b249
ToppCell	Control-Epithelial_cells-Airway_ciliated\|Control / group, cell type (main and fine annotations)	CFAP47 DNAH7 ADGB CFAP77 DNAH6 DNAH11	1.66e-05	182	131	6	fb725d10d9ed25dfc6d5bb69cfef78513f7d3e8f
ToppCell	RA-13._Vascular_Smooth_Muscle\|RA / Chamber and Cluster_Paper	CACNA1A DSTN SPEG MCAM DGKH DLC1	1.71e-05	183	131	6	818fd886e0188091310825f9145fa53328f2c979
ToppCell	facs-Pancreas-Exocrine-18m-Endothelial-endothelial_cell\|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	FLT1 FLT4 MCAM HOXA4 IL1RAPL1 DLC1	1.71e-05	183	131	6	c9d9d7dd629ce6787502103b158a07e8684a66f8
ToppCell	facs-Pancreas-Exocrine-18m-Endothelial\|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	FLT1 FLT4 MCAM HOXA4 IL1RAPL1 DLC1	1.71e-05	183	131	6	c7ef8ee2b3fcfa69cea0fdcb2041674b832933db
ToppCell	facs-Pancreas-Exocrine-18m-Endothelial-nan\|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	FLT1 FLT4 MCAM HOXA4 IL1RAPL1 DLC1	1.71e-05	183	131	6	92eee4bdd84965ae0bd1ed1c7f26a3b83ad0cdac
ToppCell	NS-moderate-d_16-33-Epithelial-Ciliated\|d_16-33 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined)	CFAP47 DNAH7 ADGB HHLA2 DNAH6 DNAH11	1.82e-05	185	131	6	5e689c2fb36ce3ac2adc8d15f67107f21cf68868
ToppCell	Ciliated_cells-B-Myositis-ILD_01\|World / lung cells shred on cell class, cell subclass, sample id	DNAH7 ADGB CFAP77 SLFN13 DNAH6 DNAH11	1.82e-05	185	131	6	f012c243343e1d1956db19b34d062e9b13de2b2a
ToppCell	15-Airway-Epithelial-Multiciliated_cell\|Airway / Age, Tissue, Lineage and Cell class	DNAH7 ADGB HHLA2 CFAP77 DNAH6 DNAH11	1.82e-05	185	131	6	0998b6bf44287eebbf39249fff23fc3689e44c4e
ToppCell	Ciliated_cells-B-IPF_01\|World / lung cells shred on cell class, cell subclass, sample id	CFAP47 DNAH7 ADGB CFAP77 DNAH6 DNAH11	1.88e-05	186	131	6	f72267d533fd0c5280d9741ceee3dd116300a7e4
ToppCell	10x5'v1-week_12-13-Endothelial-stroma-sinusoidal_EC\|week_12-13 / cell types per 3 fetal stages;per 3',per 5'	FLT1 FLT4 TMEM233 APOD HOXD4 ADGRL2	1.88e-05	186	131	6	e8ead5634686ebaa6a230eea69795d923ce9939d
ToppCell	NS-moderate-d_07-13-Epithelial-Ciliated\|d_07-13 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined)	CFAP47 DNAH7 ADGB CFAP77 DNAH6 DNAH11	1.88e-05	186	131	6	85787ff207f109ec7e3c0f729ba9bda739c2fdc9
ToppCell	390C-Epithelial_cells-Epithelial-F_(Ciliated)\|390C / Donor, Lineage, Cell class and subclass (all cells)	CFAP47 DNAH7 ADGB CFAP77 DNAH6 DNAH11	1.88e-05	186	131	6	708c5edefe36c91df27cf53c1b5101fb2030cc5a
ToppCell	390C-Epithelial_cells-Epithelial-F_(Ciliated)-\|390C / Donor, Lineage, Cell class and subclass (all cells)	CFAP47 DNAH7 ADGB CFAP77 DNAH6 DNAH11	1.88e-05	186	131	6	029390c4aaf64e6bcd86124cd4a6dd2e6f3a374b
ToppCell	renal_papilla_nuclei-Hypertensive_with+without-CKD-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thin_descending_limb_epithelial_cell\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	PKP4 LRRK2 DNAH7 FGFR1 ACMSD DNAH11	1.88e-05	186	131	6	f0c8de4f6ae9047b9108a47a2af8c5f42bc103b0
ToppCell	3'-Adult-LargeIntestine-Mesenchymal-Pericytes-Pericyte\|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract	STEAP4 DLC1 HOXD4 FILIP1L GABRA4 DNAH11	1.93e-05	187	131	6	150023e6a50c9da461f2321074d2d5e96caafb06
ToppCell	LPS-IL1RA+antiTNF-Endothelial-Endothelial-Activated_Gen_Cap\|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	FLT1 SPTLC2 DGKH APOD PARP14 SFMBT2	1.93e-05	187	131	6	dffa8447c2f3fdacf39a7258c6b4e81a25245041
ToppCell	tumor_Lymph_Node_/_Brain-Endothelial_cells-Tumor_ECs\|tumor_Lymph_Node_/_Brain / Location, Cell class and cell subclass	FLT1 FLT4 TMEM233 MCAM TACR1 ADGRL2	1.93e-05	187	131	6	be5f8c5802b0fa8cc1e274fdf06b13eb8ceb8ad4
ToppCell	Transplant_Alveoli_and_parenchyma-Epithelial-Ciliated_1\|Transplant_Alveoli_and_parenchyma / Tissue, Lineage and Cell class of Lung Cells from 10X	CFAP47 DNAH7 ADGB CFAP77 DNAH6 DNAH11	2.05e-05	189	131	6	dc440015949a768188c67661b6be63b1ead1a0f0
ToppCell	COPD-Epithelial-Ciliated\|Epithelial / Disease state, Lineage and Cell class	CFAP47 DNAH7 ADGB CFAP77 DNAH6 DNAH11	2.05e-05	189	131	6	3e77883db34722b9ce0a03ea74caefc92dc7feff
ToppCell	Severe-MAIT\|World / Disease group and Cell class	FLT4 MCAM HOXA4 HHLA2 RIMBP3C IL23R	2.11e-05	190	131	6	7a92e0d6a021be23125495927b8571e25c83204a
ToppCell	Ciliated_cells-B\|World / lung cells shred on cell class, cell subclass, sample id	DNAH7 ADGB CFAP77 SLFN13 DNAH6 DNAH11	2.11e-05	190	131	6	7031fbedc13be1a00f6333ad6d51849c3739c2e6
ToppCell	Epithelial_cells-Ciliated_cells-B\|Epithelial_cells / lung cells shred on cell class, cell subclass, sample id	DNAH7 ADGB CFAP77 SLFN13 DNAH6 DNAH11	2.11e-05	190	131	6	426a4806f6e39d4d57c6746609d30bb3ca62df7d
ToppCell	human_hepatoblastoma-Endothelial_cells\|World / Sample and Cell Type and Tumor Cluster (all cells)	FLT1 TMEM233 MCAM DGKH SFMBT2 ADGRL2	2.11e-05	190	131	6	8d6ef93d69e96cd6921816d152bea3b0710cf147
ToppCell	kidney_cells-Renal_AKI_(acute_kidney_injury)-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thin_descending_limb_epithelial_cell-Descending_Thin_Limb_Cell_Type_1\|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group	INTU DSTN LRRK2 TMEM38B FRMD4A DNAH11	2.11e-05	190	131	6	a5db902ad112a0c0a0a7f1a2e38718bb3bd11412
ToppCell	LPS_only-Endothelial-Endothelial-Activated_Alv_Cap\|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	FLT1 PKP4 DGKH PARP14 DLC1 ADGRL2	2.18e-05	191	131	6	a7b18bcf27c38ad2353c239ecb309c80f3ef3359
ToppCell	COVID-19-kidney-VWF+PLVAP+EC\|COVID-19 / Disease (COVID-19 only), tissue and cell type	FLT1 FLT4 PKP4 TMEM233 FGFR1 ADGRL2	2.18e-05	191	131	6	2f00d0b7b2ffce8eb3eb5bbae49a0d425b23c982
ToppCell	COPD-Epithelial-Ciliated\|World / Disease state, Lineage and Cell class	CFAP47 DNAH7 ADGB CFAP77 DNAH6 DNAH11	2.24e-05	192	131	6	eab1105cd1a98cfcd3d74dc5c9b89e1799bba59e
ToppCell	IPF-Epithelial-Ciliated\|IPF / Disease state, Lineage and Cell class	CFAP47 DNAH7 ADGB CFAP77 DNAH6 DNAH11	2.24e-05	192	131	6	354adc1354bf596fbc60dd45c0169688e6f45165
ToppCell	Control-Epithelial-Ciliated\|Epithelial / Disease state, Lineage and Cell class	CFAP47 DNAH7 ADGB CFAP77 DNAH6 DNAH11	2.31e-05	193	131	6	0e37d454f3735edd936ee9a5f5f516ac3aad400e
ToppCell	Brain_organoid-organoid_Kanton_Nature-Organoid-1M-Mesenchymal\|Organoid-1M / Sample Type, Dataset, Time_group, and Cell type.	LRRK2 MCAM APOD DLC1 PLA2G4A PRKCD	2.31e-05	193	131	6	e1de67ddada87229f5db0ec193a6da8745a86a64
ToppCell	LPS-antiTNF-Endothelial-Endothelial\|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	FLT1 FLT4 PKP4 DGKH APOD ADGRL2	2.31e-05	193	131	6	02f633b016ab19bfa65bfd0cf32f000549a62148
ToppCell	NS-moderate-d_0-4\|moderate / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined)	CFAP47 INTU DNAH7 ADGB DNAH6 DNAH11	2.31e-05	193	131	6	ea345d34440b25f65358a53dc72831998d1c3620
ToppCell	IPF-Epithelial-Ciliated\|Epithelial / Disease state, Lineage and Cell class	CFAP47 DNAH7 ADGB CFAP77 DNAH6 DNAH11	2.31e-05	193	131	6	ad58f5080e0ba65c845056ea6b79037b636e9c64
ToppCell	LPS-antiTNF-Endothelial\|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	FLT1 FLT4 PKP4 DGKH APOD ADGRL2	2.31e-05	193	131	6	5122b1ffba42de190061be34ecdc6176f84e56a3
ToppCell	Fetal_29-31_weeks-Endothelial-capillary_endothelial_cell_(Cap1)-D088\|Fetal_29-31_weeks / Lineage, Cell type, age group and donor	FLT1 FLT4 PKP4 TMEM233 MCAM ADGRL2	2.31e-05	193	131	6	ad2df9b77999780860141be6ec366afc0172a331
ToppCell	Brain_organoid-organoid_Kanton_Nature-Organoid-1M-Mesenchymal-choroid_plexus/mesenchymal-like_cells\|Organoid-1M / Sample Type, Dataset, Time_group, and Cell type.	LRRK2 MCAM APOD DLC1 PLA2G4A PRKCD	2.31e-05	193	131	6	b6f5a85210e60798205eaf5884cdb540f549d08a
ToppCell	CF-Lymphoid-B_cell\|Lymphoid / Disease state, Lineage and Cell class	LRRK2 PARP14 CD19 CHPT1 PIK3CA TMEM131	2.31e-05	193	131	6	7ebf20344a9a154fd2cffa281526867fcf0aded3
ToppCell	NS-critical-d_07-13-Epithelial-Ciliated\|d_07-13 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined)	CFAP47 DNAH7 ADGB CFAP77 DNAH6 DNAH11	2.38e-05	194	131	6	1ae8a10e508e672e6677f0e3c986ac30d05adeb3
ToppCell	LPS-IL1RA-Endothelial-Endothelial-Gen_Cap\|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	FLT1 PKP4 DGKH SFMBT2 DLC1 ADGRL2	2.38e-05	194	131	6	0b9cd96fa0b616da7cc90e92ff71157e9bba518f
ToppCell	LPS_only-Endothelial\|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	FLT1 PKP4 DGKH APOD SFMBT2 ADGRL2	2.38e-05	194	131	6	58f069efdefa0366033764446b9d6ffd4a17807e
ToppCell	TCGA-Blood_and_Bone_Marrow-Primary_Tumor-Diffuse_large_B-cell_lymphoma-DLBCL-1\|TCGA-Blood_and_Bone_Marrow / Sample_Type by Project: Shred V9	FLT1 IFNLR1 MB21D2 HOXD4 KLHL14 FILIP1L	2.38e-05	194	131	6	eaeeb84576270cc3fc59002ba33bff9639bb0b02
ToppCell	LPS_only-Endothelial-Endothelial\|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	FLT1 PKP4 DGKH APOD SFMBT2 ADGRL2	2.38e-05	194	131	6	bfd92ec75facb0ba55c31e5f2e089d983b3d0169
ToppCell	COVID-19-Epithelial-Ciliated_cells\|COVID-19 / Condition, Lineage and Cell class	CFAP47 DNAH7 ADGB CFAP77 DNAH6 DNAH11	2.38e-05	194	131	6	43be5fbd51dd58839cb03ca3ddd05a458e1ddb74
ToppCell	droplet-Bladder-nan-24m-Endothelial\|Bladder / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation	FLT1 FLT4 SPEG MCAM DLC1 FILIP1L	2.52e-05	196	131	6	9a90dd26e7a43e3fd55e7c5d8354cfa4cdd5a6cc
ToppCell	BAL-Severe-Epithelial-Epithelial-Ciliated\|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)	CFAP47 DNAH7 ADGB CFAP77 DNAH6 DNAH11	2.52e-05	196	131	6	686a5a0ddb00929842c1c98445c59edfcc9a8a04
ToppCell	BAL-Severe-Epithelial-Epithelial-Ciliated-\|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09)	CFAP47 DNAH7 ADGB CFAP77 DNAH6 DNAH11	2.52e-05	196	131	6	67aefc480714e4b8c9ae53c036efdc07ec6f94af
ToppCell	BAL-Severe-Epithelial-Epithelial-Ciliated\|Severe / Location, Disease Group, Cell group, Cell class (2021.03.09)	CFAP47 DNAH7 ADGB CFAP77 DNAH6 DNAH11	2.52e-05	196	131	6	ca56311edc6788e032e7635fa69b1e07035202b5
ToppCell	Severe_COVID-19-Epithelial-Ciliated\|Severe_COVID-19 / Disease group,lineage and cell class （2021.01.30）	CFAP47 DNAH7 ADGB CFAP77 DNAH6 DNAH11	2.52e-05	196	131	6	1cdef976a754c90d18b6149d367bd64e6e99b0a9
ToppCell	367C-Fibroblasts-Fibroblast-K_(Pericytes)\|Fibroblasts / Donor, Lineage, Cell class and subclass (all cells)	DSTN SPEG MCAM STEAP4 TMEM38B FILIP1L	2.52e-05	196	131	6	1d94cecd378a829dd8014fc086d7fca48c953a91
ToppCell	droplet-Bladder-nan-24m-Endothelial-endothelial_cell\|Bladder / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation	FLT1 FLT4 SPEG MCAM DLC1 FILIP1L	2.52e-05	196	131	6	04dfef1bd4ebb0e9469ae80024dc177e469a2560
ToppCell	BAL-Severe-Epithelial-Epithelial-Ciliated-\|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)	CFAP47 DNAH7 ADGB CFAP77 DNAH6 DNAH11	2.52e-05	196	131	6	69f5081e06d84ec1d9695762df801a9d0df1984b
ToppCell	367C-Fibroblasts-Fibroblast-K_(Pericytes)-\|Fibroblasts / Donor, Lineage, Cell class and subclass (all cells)	DSTN SPEG MCAM STEAP4 TMEM38B FILIP1L	2.52e-05	196	131	6	aacec48285bcb7ccf1b538187071885e3602cc49
ToppCell	5'-GW_trimst-2-LargeIntestine-Hematopoietic-Myeloid-Macrophages\|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract	DMXL2 PARP14 SFMBT2 FRMD4A AP1B1 RNASET2	2.59e-05	197	131	6	10190b877bf46ba2163d203df9dd3b498c66e52f
ToppCell	Tracheal-10x5prime-Epithelial-Epi_airway_ciliated-Deuterosomal\|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations	CFAP47 DNAH7 ADGB CFAP77 DNAH6 DNAH11	2.59e-05	197	131	6	6e4a411ef823ce9e16f420e185e21fa19d13af34
ToppCell	droplet-Bladder-nan-24m-Endothelial-endothelial_cell\|Bladder / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation	FLT1 FLT4 SPEG MCAM DLC1 FILIP1L	2.59e-05	197	131	6	488e85991c5e668afb7672942726d9295b8fc7d8
ToppCell	Tracheal-NucSeq-Epithelial-Epi_airway_ciliated-Deuterosomal\|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations	CFAP47 MELK ADGB CFAP77 DNAH6 DNAH11	2.67e-05	198	131	6	f31790442ef142f1c0c49bf3daf2d0efb193d2c9
Drug	5H-benzo(4,5)cyclohepta(1,2-b)pyridin-5-one	FLT1 FLT3 FLT4 FGFR1 FGFR2	2.16e-08	16	128	5	ctd:C561052
Drug	Simvastatin [79902-63-9]; Up 200; 9.6uM; HL60; HT_HG-U133A	FLT3 SPTLC2 ABHD2 MCAM PFKFB4 APOD KMT2D GLE1 FGFR2	1.15e-06	187	128	9	3002_UP
Drug	Sunitinib	FLT1 FLT3 FLT4	9.52e-06	8	128	3	DB01268
Drug	Proguanil hydrochloride [637-32-1]; Down 200; 13.8uM; HL60; HT_HG-U133A	FLT1 FLT4 ABHD2 PNO1 PFKFB4 CDK10 DNAH17 FGFR1	1.55e-05	196	128	8	2944_DN
Drug	felodipine; Up 200; 10uM; MCF7; HG-U133A	CACNA1A CACNA1E SPTLC2 ABHD2 MCAM KAT2A KMT2D TACR1	1.61e-05	197	128	8	337_UP
Drug	methyl ethyl ketone	FLT1 FLT3 FLT4 SPTLC2 STEAP4 CDK10 CD19 CDK13 PLA2G4A PRKCD FGFR1 FGFR2 CDK11B	2.75e-05	587	128	13	CID000006569
Drug	mesyl chloride	FLT1 IDE FGFR1	2.77e-05	11	128	3	CID000031297
Drug	lithium indium	SPIN2A SPIN2B	3.14e-05	2	128	2	CID011116062
Drug	scandium phosphate	SPIN2A SPIN2B	3.14e-05	2	128	2	CID006365269
Drug	SU4984	FGFR1 FGFR2	3.14e-05	2	128	2	DB02058
Drug	rubidium nitrate	SPIN2A SPIN2B	3.14e-05	2	128	2	CID000025731
Drug	oxindole	FLT1 FLT4 PKDREJ FGFR1	3.88e-05	34	128	4	CID000321710
Drug	ponatinib	FLT1 FLT3 FLT4 FGFR1 FGFR2	4.08e-05	68	128	5	ctd:C545373
Disease	Head and Neck Carcinoma	PIK3CA FGFR1 FGFR2	8.30e-06	10	123	3	C3887461
Disease	Malignant neoplasm of breast	FLT1 CFL1 CFL2 PFKFB4 ECT2 PKDREJ HOXA4 KMT2D PIK3CA EIF4A2 HEATR9 PLA2G4A DHX32 FGFR1 FGFR2 GABRA4	1.04e-05	1074	123	16	C0006142
Disease	Spina Bifida	CFL1 CHKA FGFR2	1.51e-05	12	123	3	C0080178
Disease	Status Dysraphicus	CFL1 CHKA FGFR2	1.51e-05	12	123	3	C0038219
Disease	Rachischisis	CFL1 CHKA FGFR2	1.51e-05	12	123	3	C0266508
Disease	JACKSON-WEISS SYNDROME	FGFR1 FGFR2	1.72e-05	2	123	2	C0795998
Disease	FGFR2-related craniosynostosis	FGFR1 FGFR2	1.72e-05	2	123	2	cv:CN231480
Disease	PFEIFFER SYNDROME	FGFR1 FGFR2	1.72e-05	2	123	2	101600
Disease	Cutis Gyrata Syndrome of Beare And Stevenson	FGFR1 FGFR2	1.72e-05	2	123	2	C1852406
Disease	Pfeiffer type acrocephalosyndactyly	FGFR1 FGFR2	1.72e-05	2	123	2	C2931888
Disease	nemaline myopathy 7 (implicated_via_orthology)	DSTN CFL1	1.72e-05	2	123	2	DOID:0110934 (implicated_via_orthology)
Disease	Jackson-Weiss syndrome	FGFR1 FGFR2	1.72e-05	2	123	2	cv:C0795998
Disease	Jackson-Weiss syndrome (is_implicated_in)	FGFR1 FGFR2	1.72e-05	2	123	2	DOID:0111337 (is_implicated_in)
Disease	Pfeiffer syndrome	FGFR1 FGFR2	1.72e-05	2	123	2	cv:C0220658
Disease	JACKSON-WEISS SYNDROME	FGFR1 FGFR2	1.72e-05	2	123	2	123150
Disease	Pfeiffer syndrome (is_implicated_in)	FGFR1 FGFR2	1.72e-05	2	123	2	DOID:14705 (is_implicated_in)
Disease	Pfeiffer syndrome (implicated_via_orthology)	FGFR1 FGFR2	1.72e-05	2	123	2	DOID:14705 (implicated_via_orthology)
Disease	Tremor, Rubral	CACNA1A ABCB7 GABRA4	3.80e-05	16	123	3	C0750940
Disease	Ataxia, Appendicular	CACNA1A ABCB7 GABRA4	3.80e-05	16	123	3	C0750937
Disease	Ataxia, Motor	CACNA1A ABCB7 GABRA4	3.80e-05	16	123	3	C0278161
Disease	Ataxia, Sensory	CACNA1A ABCB7 GABRA4	3.80e-05	16	123	3	C0240991
Disease	Abnormal coordination	CACNA1A ABCB7 GABRA4	3.80e-05	16	123	3	C0520966
Disease	Ataxia, Truncal	CACNA1A ABCB7 GABRA4	3.80e-05	16	123	3	C0427190
Disease	Craniofacial dysostosis type 1	FGFR1 FGFR2	5.16e-05	3	123	2	C2931196
Disease	acrocephalosyndactylia (is_implicated_in)	FGFR1 FGFR2	5.16e-05	3	123	2	DOID:12960 (is_implicated_in)
Disease	Pfeiffer Syndrome	FGFR1 FGFR2	5.16e-05	3	123	2	C0220658
Disease	familial hemiplegic migraine 1 (implicated_via_orthology)	CACNA1A CACNA1E	5.16e-05	3	123	2	DOID:0111181 (implicated_via_orthology)
Disease	TWIST1-related craniosynostosis	FGFR1 FGFR2	1.03e-04	4	123	2	cv:C4551902
Disease	migraine (implicated_via_orthology)	CACNA1A CACNA1E	1.03e-04	4	123	2	DOID:6364 (implicated_via_orthology)
Disease	Ataxia	CACNA1A ABCB7 GABRA4	1.52e-04	25	123	3	C0004134
Disease	bone disease (implicated_via_orthology)	FGFR1 FGFR2	1.71e-04	5	123	2	DOID:0080001 (implicated_via_orthology)
Disease	attention deficit hyperactivity disorder (implicated_via_orthology)	CHRNB2 TACR1 ADGRL2	2.15e-04	28	123	3	DOID:1094 (implicated_via_orthology)
Disease	erythrocyte aggregation	ANO5 SFMBT2	2.56e-04	6	123	2	EFO_0803375
Disease	Ovarian Mucinous Adenocarcinoma	SPEG LRRK2 MELK	2.92e-04	31	123	3	C1335167
Disease	Head and Neck Neoplasms	PIK3CA FGFR1 FGFR2	3.52e-04	33	123	3	C0018671
Disease	birth measurement, spontaneous preterm birth	RNASET2 ADGRL2	3.57e-04	7	123	2	EFO_0006917, EFO_0006921
Disease	Craniosynostosis syndrome	FGFR1 FGFR2	3.57e-04	7	123	2	cv:C0010278
Disease	hereditary ataxia (implicated_via_orthology)	CACNA1A CACNA1E	3.57e-04	7	123	2	DOID:0050951 (implicated_via_orthology)
Disease	colorectal adenocarcinoma (is_implicated_in)	FLT3 RNASET2 FGFR2	4.20e-04	35	123	3	DOID:0050861 (is_implicated_in)
Disease	Hamartoma Syndrome, Multiple	PIK3CA FGFR2	6.09e-04	9	123	2	C0018553
Disease	Malignant Head and Neck Neoplasm	PIK3CA FGFR1 FGFR2	8.26e-04	44	123	3	C0278996
Disease	hydroxy-leucine measurement	NAT8 DGKH ADGRL2	8.83e-04	45	123	3	EFO_0005276
Disease	Gastric cancer	PIK3CA FGFR2	9.25e-04	11	123	2	cv:C0024623
Disease	Neoplasm of stomach	PIK3CA FGFR2	9.25e-04	11	123	2	cv:C0038356
Disease	GASTRIC CANCER	PIK3CA FGFR2	9.25e-04	11	123	2	613659
Disease	hepatocellular carcinoma (is_implicated_in)	FLT3 PIK3CA CDK13 FGFR1 FGFR2	9.90e-04	181	123	5	DOID:684 (is_implicated_in)
Disease	psoriasis	FLT3 CFL1 PAK5 REV3L IFNLR1 IL23R	1.02e-03	273	123	6	EFO_0000676
Disease	Neurogenic Inflammation	MCAM TACR1	1.11e-03	12	123	2	C0600467
Disease	thyroid gland carcinoma (is_marker_for)	FLT1 FLT4	1.11e-03	12	123	2	DOID:3963 (is_marker_for)
Disease	Skin Abnormalities	AP1B1 FGFR2	1.30e-03	13	123	2	C0037268
Disease	monoclonal gammopathy	SFMBT2 FRMD4A HFM1	1.42e-03	53	123	3	EFO_0000203
Disease	Metastatic melanoma	FLT4 PAK5 STK38	1.50e-03	54	123	3	C0278883
Disease	Kartagener syndrome (implicated_via_orthology)	AP1B1 DNAH11	1.52e-03	14	123	2	DOID:0050144 (implicated_via_orthology)
Disease	Hypothermia, natural	CHRNB2 PRKCD	1.52e-03	14	123	2	C0020672
Disease	vascular dementia (biomarker_via_orthology)	FLT1 FGFR1	1.52e-03	14	123	2	DOID:8725 (biomarker_via_orthology)
Disease	interleukin 18 receptor 1 measurement	IL1RL1 IL23R	1.75e-03	15	123	2	EFO_0008178
Disease	Common Variable Immunodeficiency	CD19 PRKCD	1.75e-03	15	123	2	C0009447
Disease	Synostotic Posterior Plagiocephaly	FGFR1 FGFR2	1.99e-03	16	123	2	C1833340
Disease	vitamin C measurement	CHPT1 SLC23A1	1.99e-03	16	123	2	EFO_0600003
Disease	Craniosynostosis, Type 1	FGFR1 FGFR2	1.99e-03	16	123	2	C4551902
Disease	Acrocephaly	FGFR1 FGFR2	1.99e-03	16	123	2	C0030044
Disease	Trigonocephaly	FGFR1 FGFR2	1.99e-03	16	123	2	C0265535
Disease	Scaphycephaly	FGFR1 FGFR2	1.99e-03	16	123	2	C0265534
Disease	Synostotic Anterior Plagiocephaly	FGFR1 FGFR2	1.99e-03	16	123	2	C2931150
Disease	Metopic synostosis	FGFR1 FGFR2	1.99e-03	16	123	2	C1860819
Disease	cathepsin L1 measurement	LRRK2 ADGB	1.99e-03	16	123	2	EFO_0010619
Disease	Benign neoplasm of stomach	PIK3CA FGFR2	2.25e-03	17	123	2	C0153943
Disease	Neoplasm of uncertain or unknown behavior of stomach	PIK3CA FGFR2	2.25e-03	17	123	2	C0496905
Disease	Brachycephaly	FGFR1 FGFR2	2.25e-03	17	123	2	C0221356
Disease	Carcinoma in situ of stomach	PIK3CA FGFR2	2.25e-03	17	123	2	C0154060
Disease	carcinoma (implicated_via_orthology)	FLT1 FLT3 FLT4	2.45e-03	64	123	3	DOID:305 (implicated_via_orthology)
Disease	event free survival time, urinary bladder cancer	MYT1L SFMBT2	2.81e-03	19	123	2	EFO_0000482, MONDO_0001187
Disease	leukemia (implicated_via_orthology)	HOXA4 HOXD4	2.81e-03	19	123	2	DOID:1240 (implicated_via_orthology)
Disease	Craniosynostosis	FGFR1 FGFR2	3.12e-03	20	123	2	C0010278
Disease	cortisol measurement	DGKH SERPINA2	3.12e-03	20	123	2	EFO_0005843
Disease	autoimmune thyroid disease, systemic lupus erythematosus, type 1 diabetes mellitus, ankylosing spondylitis, psoriasis, common variable immunodeficiency, celiac disease, ulcerative colitis, Crohn's disease, autoimmune disease, juvenile idiopathic arthritis	LRRK2 ADGRL2 IL23R	3.16e-03	70	123	3	EFO_0000384, EFO_0000676, EFO_0000729, EFO_0001060, EFO_0002609, EFO_0003898, EFO_0005140, EFO_0006812, MONDO_0005147, MONDO_0007915, MONDO_0015517
Disease	Stomach Carcinoma	PIK3CA FGFR2	3.44e-03	21	123	2	C0699791
Disease	Sarcoma	FLT4 PIK3CA	3.44e-03	21	123	2	C1261473
Disease	Conventional (Clear Cell) Renal Cell Carcinoma	FLT1 FLT4 LRRK2 PIK3CA	3.48e-03	148	123	4	C0279702
Disease	Attention Deficit Disorder	CHRNB2 TACR1	3.77e-03	22	123	2	C0041671
Disease	Minimal Brain Dysfunction	CHRNB2 TACR1	3.77e-03	22	123	2	C1321905
Disease	impotence (biomarker_via_orthology)	CFL1 MCAM	3.77e-03	22	123	2	DOID:1875 (biomarker_via_orthology)
Disease	Bipolar Disorder	CACNA1A DGKH APOD PLA2G4A FGFR1 TACR1 FGFR2	3.93e-03	477	123	7	C0005586
Disease	Ovarian Serous Adenocarcinoma	LRRK2 FGFR2	4.12e-03	23	123	2	C1335177
Disease	idiopathic pulmonary fibrosis (is_marker_for)	IL1RL1 FGFR2	4.12e-03	23	123	2	DOID:0050156 (is_marker_for)
Disease	Disproportionate short stature	ANO5 FGFR1 FGFR2	4.13e-03	77	123	3	C0878659

Protein segments in the cluster

Peptide	Gene	Start	Entry
KGVEMLWHPSVVKPY	PKP4	816	Q99569
AKKITEWPPFEYMIL	CACNA1A	91	O00555
EPAKLEVKFSWFMPS	APOD	101	P05090
FIFWAPESAPLKSKM	CFL1	101	P23528
RKYKPPVKLDTLWHM	CFAP77	261	Q6ZQR2
VKFLLAWMIPDVPKD	ANO5	846	Q75V66
YAKKLIDWPPFEYMI	CACNA1E	81	Q15878
YEFELWPMLLSKAII	ADGB	231	Q8N7X0
PGYMDKVWELLKEIL	ADGB	281	Q8N7X0
FPEPLTWMDKLVVEY	ABHD2	386	P08910
KIYPEWPVVFFMKGL	A4GNT	76	Q9UNA3
PHYMPVKDWEVLKTI	DNAH11	2796	Q96DT5
VPVMFSYWAKPEDTL	ACMSD	76	Q8TDX5
LTEPVVMALLKYWPK	PPP2R5C	281	Q13362
VMALLKYWPKTHSPK	PPP2R5C	286	Q13362
KYWPKTHSPKEVMFL	PPP2R5C	291	Q13362
KDPLQAADKIYFMPW	ADGRL2	161	O95490
FWKMLILIKEDYFPR	GLE1	641	Q53GS7
YVAPKAVWLPAMKAK	AP1B1	716	Q10567
IWPGYSELPAVKKMT	CDK11B	661	P21127
KEKFIPPELSMWDYF	DMXL2	2446	Q8TDJ6
KEELMFFLWAPELAP	DSTN	96	P60981
FFLWAPELAPLKSKM	DSTN	101	P60981
PLSGYSITKKMPEWV	DHX32	651	Q7L7V1
AVWPDVIKLPYFNTM	CDK13	936	Q14004
TTKLMWIPDTKGVYP	DCAF7	71	P61962
LPLWTPKIMIAALDY	RIMBP3B	1566	A6NNM3
LPLWTPKIMIAALDY	RIMBP3C	1566	A6NJZ7
VSLGTPIMKPEWIYK	ECT2	231	Q9H8V3
WPFMEPVKKSEAPDY	KAT2A	751	Q92830
IMRGKYDVPKWLSPS	MELK	221	Q14680
EVPKRKSLVGTPYWM	PAK5	596	Q9P286
PVKWMAPEALFDRVY	FGFR2	666	P21802
MLYDIVPVVSFKGWP	MB21D2	231	Q8IYB1
MPPLDLKYEVAFWKE	IFNLR1	151	Q8IU57
GKTLVQKKPTMYPEW	PRKCD	41	Q05655
YWEKLIYLLRPPMES	GARIN4	166	Q8IYT1
EWKKGFEVIYMSEPI	HSP90AB4P	411	Q58FF6
YAMKEIEPEPDFILW	SMPDL3B	76	Q92485
FIFWAPESAPLKSKM	CFL2	101	Q9Y281
DVSPLIYWMKGEKFI	IL1RAPL1	276	Q9NZN1
WLAEFRKYLEKPITM	DLAT	631	P10515
PEWKMPLFLVFLVIY	OR5H2	26	Q8NGV7
DDKKEVRAPSPYWIM	PDZD9	211	Q8IXQ8
EKFKVPVEVLTRWMY	PDE6C	536	P51160
ELTQNPLKKIWMPYS	PFKFB4	6	Q16877
VLSVYPRPIITWKMD	HHLA2	161	Q9UM44
LIKMYTWEKPFAKII	ABCC11	351	Q96J66
VKEYGCAPWPMVEKL	LRRK2	2096	Q5S007
PKSEMIYTWTKGPEK	GABRA4	196	P48169
DPTMYKCLWKPDLFF	GLRB	131	P48167
TPLKENWMKIFTPIV	PNO1	86	Q9NRX1
RWSIMTYELKLPPKA	DGKH	456	Q86XP1
AQMYCLVKDWPPIKP	PIK3CA	581	P42336
ALKQPAVVYPWMKKV	HOXD4	126	P09016
LPWLNIKIVYMAPIK	HFM1	326	A2PYH4
TDQKKAPPVMAYWVV	INTU	891	Q9ULD6
SKYKVNPIKVDPTMW	PARP14	396	Q460N5
PVKWMAPESLFEGIY	FLT3	851	P36888
IKPKMWSESSLDEPY	FRMD4A	606	Q9P2Q2
AFFILPDPKKMWQLE	SERPINA2	276	P20848
PDPKKMWQLEEKLTY	SERPINA2	281	P20848
VFVDPEELKWMPYVK	DNAH6	1896	Q9C0G6
KFWKHVRYQMPVPSK	IL1RL1	526	Q01638
VIKEMYPKPFFKTWA	IGSF1	771	Q8N6C5
DDEKKTWKILTIMPY	KLHL14	346	Q9P2G3
ELMEKFWIPYIHNLK	DNAH17	3376	Q9UFH2
PVKPMTPKVVTLWYR	CDK10	191	Q15131
LMSPKLYVWAKDRPE	CD19	151	P15391
VAPYWTSPEKMEKKL	FGFR1	151	P11362
AKSTPWQEDIYEKPM	FILIP1L	126	Q4L180
PKWLFGTMEKYLKEV	CHKA	246	P35790
HPKILYDTVPVMWLK	DNAH7	3946	Q8WXX0
LIPKWLYEDIPNMKN	IL23R	391	Q5VWK5
TKPVNWLKPVYMLDS	TMEM30A	231	Q9NV96
YLSPKWIKMFVLDEA	EIF4A2	171	Q14240
IKNIWIPMKPYYTKV	ATP5MJ	6	P56378
PYPALIKDTAMSKLW	IDE	546	P14735
EAPKSWMVREKYIRP	SLFN13	326	Q68D06
PEMAEEFWYLLKLTI	CFAP47	2626	Q6ZTR5
EPVVYPWMKKIHVSA	HOXA4	191	Q00056
IWVVMAIPFYKARKL	C18orf63	66	Q68DL7
WAKMNKLPFPKIDPY	PLA2G4A	596	P47712
AIFGPPWMAFKERKV	MCAM	426	P43121
PKYLSKIVIFDMPWL	MOSPD2	176	Q8NHP6
VVKKYWAITVHVPMP	RPUSD4	181	Q96CM3
IRMEPWDYPAKQEDK	MRPS34	196	P82930
MTPLAPWDPKYEAKA	SAP25	1	Q8TEE9
TQKAYEDVPWDKMLP	SPATA48	241	A4D263
WDMAKYPVKQPLVSV	ATP6V1C2	106	Q8NEY4
YKKVMNWKETLTFPP	STK38	331	Q15208
MVKVWPEVTDPEKFV	TRMT44	316	Q8IYL2
KTEEDVPMPKNYLWL	TMEM233	26	B4DJY2
LPLWTPKIMIAALDY	RIMBP3	1566	Q9UFD9
IYMFLPITKWLPAYK	SLC26A5	61	P58743
PKMPEVKDSDAVYVW	PKDREJ	316	Q9NTG1
MIEWPEHPNKIYEKV	TACR1	181	P25103
AIVIIKYIWPDKEMT	SLC38A7	216	Q9NVC3
KYIWPDKEMTPGNIL	SLC38A7	221	Q9NVC3
PIMKAWFYITYEKDP	SPIN2A	156	Q99865
DLMPSYDEKIDIWKI	POMK	271	Q9H5K3
WAVPKFMKRIKVPDY	DLC1	1056	Q96QB1
MAPWVKVVFLEKLPA	CHRNB2	331	P17787
IKAMLSYVWPKDRPD	ABCB7	121	O75027
KYWEMMPPTILIDLL	NCAPG2	406	Q86XI2
TMWDYTIPILEIKLK	CHPT1	211	Q8WUD6
KLMEKYPCAVPLWVG	CYP4Z1	71	Q86W10
PLEPPKESMWYRKLK	PNMA5	146	Q96PV4
KHFWPEVPKKAYDME	TNMD	51	Q9H2S6
IKDLLPEMRAYWPDV	RNASET2	86	O00584
DYLKSFMETEVKPLW	UBN2	636	Q6ZU65
PLIIPTDYWKKMAKV	XPNPEP1	121	Q9NQW7
LKDMPKKWLFLPFED	NXNL1	91	Q96CM4
MELYKKLAPLKDFWP	REV3L	1011	O60673
VVVEGKPLPDIMWYK	SPEG	1506	Q15772
KPLPDIMWYKDEVLL	SPEG	1511	Q15772
MLYKIEDVPPWYLCI	SLC23A1	31	Q9UHI7
PWKKILILVEGIYSM	SPTLC2	306	O15270
PIMKAWFYITYEKDP	SPIN2B	156	Q9BPZ2
KLWEIPPYETKGVMR	TMEM131	266	Q92545
LPLKWMAPESIFDKV	FLT4	1076	P35916
MFLYPWLEYPDKTKE	HEATR9	16	A2RTY3
LMPPDAIKEKYTDWT	SFMBT2	141	Q5VUG0
PEGDEWLKMSYPAKV	TMEM38B	171	Q9NVV0
AKEIEKYPLQLFPMW	STEAP4	186	Q687X5
KWPPFAVDLTMELYQ	ACP6	351	Q9NPH0
FPTPPYWKTAKEMVA	RALGAPB	211	Q86X10
PVWKEEPFVFEKILM	PLCB2	731	Q00722
LAKKELAYVPIIGWM	AGPAT4	121	Q9NRZ5
IKEPEILKGWMNEIY	TEX2	541	Q8IWB9
MPLYSVTVKWGKEKF	USP14	1	P54578
SMKVKAFPSPEVVWL	FLT1	356	P17948
LPLKWMAPESIFDKI	FLT1	1061	P17948
PYIAIDWEPEMKKRY	USP11	741	P51784
MVVPEKEQSWIPKIF	TRPM4	1	Q8TD43
PYVITLLEDGKEPWM	ZNF181	51	Q2M3W8
EEVPVYVPKWMPFKE	ZW10	711	O43264
MKLWRKVPAADKAPY	KMT2D	2046	O14686
FLAKKPWTEYVDMTL	NAT8	76	Q9UHE5
CWDLPVDYTKMKPRR	MYT1L	816	Q9UL68